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Biocatalysis of Fumarate derivatives by 
Flavocytochrome c3 
Abstract 
Flavocytochrome C3 (Fcc3) is a 63.8 kDa soluble fumarate reductase produced by the 
bacterium Shewanella frigidimarina when grown under anaerobic conditions with 
fumarate present. It is composed of a single polypeptide chain that incorporates four 
c-type haems and a non-covalently bound flavin adenine dinucleotide molecule as 
redox co-factors. Electrons are transferred to the active site where they are used for 
the catalytic reduction of fumarate to succinate. As the kinetics of fumarate reduction 
have previously been established (k cat = 509 ± 15 Km = 25 ± 2 tM at pH 7.2), the 
aim of this project was to investigate the ability of Fcc3 to reduce alternative 
substrates, particularly those that may result in the production of chiral molecules. 
Fcc3 is able to reduce 2-methylfumarate to 2-methylsuccinate in vitro, with a kcat of 
8.97 ± 0.43 s 1 , and a Km of 31.7 ± 8.5 tM at pH 7.2. Circular dichroism 
spectroscopy revealed that reduction of 2-methylfumarate by wild-type Fcc3 is 
stereospecific, producing S-methylsuccinate. The crystal structure of wild-type Fcc3 
with 2-methylfumarate bound was solved to 1.5 A and showed that the mode of 2-
methylfumarate binding to the active site always results in the production of S-
methylsuccinate. A range of fumarate derivatives were tested as potential substrates 
but wild-type Fcc3 did not catalyse the reduction of anything other than fumarate and 
2-methylfumarate. In order to find out if the substrate specificity of Fcc3 could be 
altered, active site residues involved in Hydrogen-bonding with substrate were 
substituted by site-directed mutagenesis. Subsequent kinetic studies demonstrated 
that most of the mutant enzymes were still able to reduce fumarate and 2- 
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methylfumarate, although at rates differing from that measured for wild-type Fcc3. 
Crystal structures were obtained for the mutants T377A and H365G at 2.0 A and 1.9 
A respectively. When T377 is replaced with alanine, it can be seen from the crystal 
structure that the substrate is held by two less hydrogen-bonds than when bound to 
wild-type and is no longer held in the characteristic "twisted" conformation, an 
important aspect of the catalytic mechanism. All crystal structures obtained for Fcc3 
so far have shown the protein in the "closed" conformation. Other studies have 
demonstrated that the clamp domain of Fcc 3 is capable of movement and can exist in 
an "open" form where substrate is not bound. The crystal structure of H365G was 
obtained in the "open" conformation and is the only structure of Fcc 3 without 
substrate bound. Previous theoretical modelling studies had predicted that some 
mutants (especially l-1365G) may be able to catalyse the reduction of some mono-
acids. However, it appears that this is not the case as none of the engineered forms of 
Fcc3 were able to reduce any substrates other than fumarate and 2-methylfumarate. 
Fcc3 is therefore a highly substrate-specific fumarate reductase. 
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Abbreviations 
Amino acids 
Alanine Ala A Leucine Leu L 
Arginine Arg R Lysine Lys K 
Asparagine Asn N Methionine Met M 
Aspartic acid Asp D Phenylalanine Phe F 
Cysteine Cys C Proline Pro P 
Glutamic acid Glu E Serine Ser S 
Glutamine Gln Q Threonine Thr T 
Glycine Gly 0 Tryptophan Trp W 
Histidine His H Tyrosine Tyr Y 




c Extinction coefficient 
Fcc3 Flavocytochrome c3 
FPLC Fast protein liquid chromatography 
AGO Standard free energy change 
IFcc3 Iron-induced Flavocytochrome c3 
LB Luria Bertani 
ox oxidised 
PDB Protein Data Bank (http://www.rcsb.org/pdb)  
red reduced 
QFR Quinol: Fumarate Reductase 
SQR Succinate: Quinone Oxidoreductase 
Chemicals 
ADP Adenosine Di-phosphate 
ATP Adenosine Tr-phosphate 
DTT Dithiothreitol 
DMSO Dimethyl Sulphoxide 
FAD Flavin Adenine Dinucleotide 
FMN Flavin Mononucleotide 
IPTG Isopropyl-3-D-thiogalactopyranoside 
MK Menaquinone 
MV Methyl Viologen 
NADH 13-Nicotinamide Adenine Dinucleotide 
NADPH -Nicotinamide Adenine Dinucleotide 
SDS Sodium Dodecylsulphate 
UQ Ubiquinone 
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Buffers 
C HES 2- [N-Cyclohexylamino]ethanesulfonic acid 
HEPES N- [2-Hydroxyethyl]piperazine-N' -[2- 
ethanesulfonic acid] 
KPi Potassium Phosphate: K 2HPO4/KH2PO4 
MES 2- [N-Morpholino] ethanesulfonic acid 
MOPS 3-[N-Morpholino]propanesulfphonic acid 
TRIS Tris [hydroxymethyl]aminoethane 
Standard units 
m 	metre 	 M 
	
molar 
g gram degree Celcius 
1 	litre 	 V 
	
volt 
s second A Angstrom 
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1.0 Redox co-factors 
Redox reactions in biology are catalysed by oxidoreductase enzymes and many 
biochemical processes depend on efficient electron transfer. Broadly, there are two 
types of electron transfers; intermolecular electron transfer in which mobile electron 
carriers donate or accept electrons to and from other carriers or oxidoreductase 
enzymes, and intra-molecular transfer in which electrons are passed between different 
redox centres within the same protein. A wide variety of redox-active centres are 
used in biology. Some proteins incorporate centres that contain bound metal ions, 
examples of which include iron, copper, nickel and molybdenum. Non-metallic redox 
cofactors such as flavins may also be bound within proteins but others, like NADH 
and quinones, exist freely within the cell. Some examples will be discussed in the 
following pages. 
1.0.1 Haem co-factors 
Haems are redox-active centres that contain an iron atom which is ligated by four 
nitrogen atoms from surrounding pyrole groups. In its simplest form, this system is 
termed protoporphyrin IX and constitutes the b-type haem (figure 1.1 b). This is the 
most common type of haem and is incorporated by proteins such as cytochrome b 5 
[Durley and Mathews, 1996] and the cytochrome bc1 complex (discussed later in this 
thesis) [Iwata et a!, 1998]. Variations of the protoporphyrin IX give rise to four major 
types of haem, classed as haems a, b, c and d. The a-type haems have a 
hydroxyethylfamesyl chain attached via the C313 carbon and a formyl group on the 
C3A carbon (figure 1.1 a). This type of haem is incorporated by the cytochrome c 
oxidase complex which forms part of the aerobic electron transport chain [Yoshikawa 
et a!, 1998]. The c-type haems (figure 1.1 c) bind covalently to cysteine residues 
CH, 
a) b) 
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Figure 1.1 Haem co-factors 
Haem a 
	 Haem b 
C) 
Haem C 
Types of haem co-factors incorporated by proteins, a) Haem a has a hydroxyethylfarnesyl chain 
attached via the C3B carbon and aformyl group on the C3A carbon b) protoporphyrin JX the most 
commonly found type of haem C) haem c which attatches to the protein backbone via covalent thioether 
linkages with cysteine residues 
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within proteins by means of a condensation reaction with the two vinyl groups of the 
porphyrin ring to form thioether linkages. An example of this is found in the soluble 
electron transporter cytochrome c. The d-type haems have fewer double bonds and 
contain additional carboxylic acid groups on the periphery of the ring system. In 
most cases, iron atoms within haems exist in either the ferric (Fe 3 ) or ferrous (Fe 2 ) 
oxidation states and transfer one electron at a time. 
1.0.2 Iron-sulpur redox centres 
Iron can also be incorporated within proteins in the form of iron-sulphur clusters. 
There are five different types that vary according to the number of iron and sulphur 
atoms present and in the way in which they are ligated. Examples are shown in figure 
1.2. The simplest type contains only one iron atom which is coordinated by four 
sulphur atoms provided by cysteine residues. There are two types of [2Fe2S] clusters: 
one is the "Rieske" cluster which is ligated by two S atoms fom cysteines and two N 
atoms from histidines (figure 1.2 a). The other type of [2Fe2S] is coordinated by four 
cysteines. The fourth type of cluster is the [3Fe4S] cluster (figure 1.2 b)) coordinated 
by three cysteines, and the fifth is the [4Fe4S] cluster (figure 1.2 c)), coordinated by 
four cysteines. Like haem co-factors, iron-sulphur clusters participate in one-electron 
transfers. 
1.0.3 Flavin 
Flavins are incorporated into proteins as either flavin mononucleotide (FMN) or 
flavin adenine dinucleotide (FAD) molecules. They may be covalently attached to 
proteins via cysteine, tyrosine or histidine residues, or bound non-covalently through 
hydrogen-bonding and van der Wants interactions. The redox active part of flavin is 
-3- 
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Figure 1. 2 Iron-sulphur clusters 
a) 
C) 
Stick representations of different types of iron-sulphur clusters incorporated within proteins. Sulpur 
atoms are shown in yellow, iron atoms are whown in red and amino acid residues that ligate the 
clusters are shown in grey. a) [2Fe2SJ cluster also called the "Rieske cluster" to differentiate it from 
other [2Fe2S] clusters. They are ligated by two S atoms from cysteine residues and two N atoms from 
histidine residues. b) [3Fe4S] cluster which is ligated by 3 cysteine residues. c) [4Fe4S] cluster which 
is ligated by four cysreine residues. 
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Flavin adenine dinucleotide. FAD can exist in three different  oxidation states: the oxidised quinone, 
semiquinone and the fully reduced hydroquinone. They can accept or transfer either one or two 
electrons at a time and in this way they often act as tranceivers. 
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the isoalloxazine ring which can exist in three different oxidation states: the fully 
oxidised quinone state, the semiquinone (one-electron reduced) and the fully reduced 
hydroquinone state (figure 1.3). This means that flavin can accept one electron at a 
time but transfer two electrons simultaneously (or the reverse - accept two electrons 
and then transfer them one at a time). In this way flavin acts as a transceiver, a 
property that is often exploited by proteins that catalyse two-electron oxidations or 
reductions, including Flavocytochrome c3. 
1.0.4 Quinones 
Quinones are mobile hydrophobic molecules that are constrained within cell 
membranes and like flavins, are able to exist in three oxidation states. As will be 
discussed later, they are essential components of respiratory electron transport chains. 
Two examples of quinone are shown in figure 1.4. Ubiquinone is shown in 1.4 a) and 
is generally utilised by cells that respire aerobically. Menaquinone (shown in 1.4 b)) 
has a lower reduction potential than ubiquinone and is found in cells that respire 
anaerobically. The figure shows both types in the fully oxidised and fully reduced 
states. 
1.0.5 NADH/NADPH 
Nicotinamide Adenosine Dinucleotide (NADH) and Nicotinamide Adenosine 
Dinucleotide Phosphate (NADPH) are mobile electron carriers which are soluble and 
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a) Ubiquinone (oxidisedform) and ubiqunol (reduced) which diffuse  freely through the plasma 
membrane where they transfer electrons between protein complexes during anaerobic respiration. b) 
Menaquinone (oxidised) and menaquinol (reduced) which perform the same function, but are used 
preferentially during anaerobic respiration. c) NADP (oxidised) and NADPH (reduced) which are 
identical to NA  111 apart from the additional phosphate group. Both molecules are soluble and act 
as electron carriers in the cytoplasm. 
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NADPH, the two molecules are identical, although NADH is generally involved in 
catabolic processes while NADPH is utilised in anabolic processes. Both always 
transfer two electrons in the form of a hydride (H) and share the same reduction 
potential. Figure 1.4 c shows a molecule of NADPH in the oxidised and reduced 
form. 
1.1 Overview of Aerobic Metabolism 
All organisms on earth require energy, which can be utilised by cells in the readily 
accessible form of Adenosine tn-phosphate (ATP). ATP is continually generated 
during the catabolic breakdown of lipids, proteins and carbohydrates in a process 
called respiration. The most common form of respiration is Aerobic respiration, 
which couples the breakdown of food molecules to the reduction of molecular oxygen 
to water. The complete oxidation of glucose can be represented as the equation: 
C61-11206 + 602 	o 6CO2 + 61-120 + 38ATP AG" = -2823kJ.mol 
It can be seen that oxidation of glucose is a highly exergonic process but this energy 
is not released all at once. Instead it is released gradually via many enzymatically 
controlled reactions. Figure 1.5 shows an overview of the different stages of aerobic 
respiration (breakdown products from proteins and lipids also enter either glycolysis 
or the citric acid cycle but have been omitted for simplicity). Electrons are captured 
at various steps of glycolysis and the citric acid cycle by the electron carriers NAD 
and FAD, where they are reduced to NADH and FADH 2 . These reducing equivalents 
then enter the electron transport chain where they are oxidised. The energy released 
by the stepwise transfer of electrons between a series of protein complexes before 
being transferred to the terminal electron acceptor oxygen, powers the production of 
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Overview of the catabolic breakdown of carbohydrates that generates cell energy in the form of 
Adenosine tn-phosphate (A TP). Carbohydrates are enzymatically broken down to glucose which then 
enters the first major stage of respiration - Glycolysis. Glycolysis results in production of two 
molecules of pyruvate which, after conversion to acetylCoA, then enter the citric acid cycle. The citric 
acid cycle consists of a series of reactions which harvest electrons from the complete oxidation of 
pyruvate, in the form of NADH/H and FADH,. These reducing equivalents then enter the electron 
transport chain. Energy released as electrons move along the chain and ultimately to oxygen, powers 
production of A TP. When no oxygen is present, the citric acid cycle shuts down and only the glycolytic 
pathway can proceed. This leads to the net production of only 2A TP (compared to the 38 A TP 
produced by the complete oxidation of glucose. 
S 
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ATP. NAD and FAD can then re-enter glycolysis and the citric acid cycle to ensure 
the whole respiratory process continues. In the absence of oxygen, simple life-forms 
such as fungi and bacteria are able to respire anaerobically using alternative terminal 
electron acceptors to oxygen, or by the process of fermentation. 
1.1.1 Glycolysis 
Glycolysis takes place in the cell cytosol or the cytoplasm of bacteria. It is the 
process by which glucose is broken down to two molecules of pyruvate involving ten 
reactions, each catalysed by different enzymes. Pyruvate is then transported to the 
matrix of the mitochondrion where it is converted to AcetylCoenzymeA by the 
pyruvate dehydrogenase complex before entering the citric acid cycle. In addition to 
pyruvate, glycolysis results in the net formation of two ATP molecules plus two 
NADH. The formation of ATP occurs by the direct transfer of a phosphate from 
substrate (in this case a product of glucose catabolism) to ADP (Adenosine di-
phosphate) and is an example of substrate level phosphorylation which differs from 
oxidative phosphorylation discussed later. When no oxygen is present, the citric acid 
cycle and electron transport chains do not function because reducing equivalents 
cannot be oxidised due to the lack of a terminal electron acceptor. As glycolysis still 
results in the production of ATP, simple organisms can survive if they are able to 
regenerate NAD. They do this by converting pyruvate to waste products such as 
lactate or ethanol, a process called fermentation. Lactic acid fermentation involves 
the direct reduction of pyruvate to lactate by NADH and is catalysed by lactate 
dehydrogenase (figure 1.5). This regenerates NAD which can then be used to sustain 
the glycolytic process. This also occurs temporarily in muscle tissue in humans under 
-10- 
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Figure 1.6 Fermentation ofpyruvate 
Lactate 
dehydrogenase 
GLI COS E 	 2 pyruvate 	 0 Lactate + NAD 
= -196 kJ.mol' 
Alcohol 
dehydrogenase 
GLUCOSE - 2 pyruvate 	mo Acetaldehyde + NA DH 	PP Ethanol + NAD 
= -239 kJ.moi' 
When oxygen is absent, NAD can be regenerated by either reduction to Lactate, or by a No-step 
reduction to ethanol. Fermentation releases less energy (Id) than aerobic respiration per mole of 
glucose but it is enough to sustain single celled organisms. 
conditions when oxygen supply cannot keep up with energy demands, such as during 
strenuous exercise. In yeast, pyruvate can be converted to alcohol in a two-step 
process that involves decarboxylation of pyruvate to acetaldehyde by pyruvate 
decarboxylase, before reduction to ethanol by NADH catalysed by alcohol 
dehydrogenase. It can be seen from figure 1.6 that both of these fermentation 
processes do not harness as much energy as the complete oxidation of glucose, but 
enough to enable single-celled organisms to survive. 
1.1.2 Citric acid cycle 
The citric acid cycle takes place in the mitochondrial matrix of eukaryotic cells or the 
cytoplasm of bacterial cells. Its purpose is to produce reducing equivalents that enter 
the electron transport chain. It consists of a continuous cycle of eight reactions that 
begins with the addition of AcetylCoA to oxaloacetate, which is always regenerated at 
- 11 - 
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H2O 	 NADHfH 
Succinyl CoA  
GDP 
ADP 	 ± HP042 
+ HPO4 GTP 
+GDP 
Schematic of the citric acid cycle showing the various steps at which NADH/H and FADH 2 are 
produced. The cycle always regenerates oxaloacetate and Co-enyme A so that it can run continuously, 
provided that oxygen is present in order to regenerate NA  and FAD via electron transport. 
oxaloacetat 
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the end of the cycle (figure 1.7). At various stages energy from the oxidation of 
organic molecules is harvested by coupling it to the reduction of NAD and FAD. In 
addition to this, ATP is generated by the substrate phosphorylation of GDP 
(guanosine diphosphate) to GTP during the conversion of succinylCoA to succinate 
catalysed by succinylCoA synthetase. GTP is subsequently converted to ATP by 
nucleoside diphosphate kinase. In many organisms ATP is produced directly at this 
step by phosphorylation of ADP instead of GDP. The oxidation of succinate to 
fumarate is carried out by succinate quinone oxidoreductase (SQR), which as well as 
contributing to the citric acid cycle, also functions as part of the electron transport 
chain where it is often referred to as complex II. This multi-subunit enzyme contains 
an FAD molecule at its active site which is reduced to FADH 2 during the oxidation of 
succinate. Unlike the other enzymes involved in the citric acid cycle, the SQR 
complex is embedded in the inner mitochondrial membrane (or the periplasmic 
membrane in bacteria). Electrons from FADH 2 are fed into the electron transport 
chain by SQR via quinones that diffuse freely within the membrane, where they 
interact with the other complexes of the chain. The complete oxidation of two 
molecules of pyruvate (from one molecule of glucose) during the citric acid cycle 
results in production of 6NADH, 2FADH2 and 2 molecules of ATP. 
1.1.3 Aerobic electron transport chain. 
The aerobic electron transport chain is composed of five multi-subunit protein 
complexes including the ATP synthase which is responsible for generation of cell 
energy in the form of ATP (figure 1.8). When the inner surface of the inner 
mitochondrial membrane is viewed under the electron microscope it appears to have a 
rough surface, which is due to peripheral regions of these complexes which exist in 



























QH2 	 QH 2 
... 	 ..... ..... 
Complex i 	
Complex HI 
- 	 - 
Complex II 
NADH NAD 	 /•__\ 
succinate fuma rate 
CYTOPLASM / MITOCHONDRIAL MATRIX r1i1 
	
ATP 
Schematic of the Aerobic electron transport chain. NADH transfers electrons to ubiquinol through complex! regenerating NAD . Oxidation otsuccinale 
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Biocatalysis offumarate derivatives byflavocytochrome c 3 
numerous copies and are densely packed together. Complexes I - IV are 
oxidoreductases which transfer electrons in an exergonic manner from redox centres 
that have more negative reduction potentials to centres that have more positive 
reduction potentials. Complexes I, III and IV utilise the energy released by these 
electron transfers to drive the pumping of protons into the intermembrane space of 
mitochondria or the periplasm in bacterial cells. The inner membrane is not very 
permeable to H ions so consequentially an electrochemical gradient of protons 
(L\j.xH) is created between the intermembrane space and the matrix of mitochondria. 
This results in a potential difference (AV) across the membrane (due to the difference 
in charge) and also a concentration gradient (ApH) which combined, constitute the 
proton motive force (Ap). Protons can only re-enter the matrix via channels enclosed 
by the ATP synthases (also called complex V). The potential energy of the proton 
motive force is harnessed by ATP synthase as protons move down the gradient to the 
negative side of the membrane, driving conformational changes that enable the 
catalytic phosphorylation of ADP to ATP. This process is termed "oxidative 
phosphorylation" because it is coupled to the reduction of molecular oxygen by the 
electron transport chain. It is also called "chemiosmosis" as the diffusion of H ions 
from a region of high concentration to a region of low concentration is analogous to 
the movement of water molecules across cell membranes. A more detailed 
description of each complex that constitutes the aerobic electron transport chain now 
follows. 
1.1.4 Complex I 
Complex I of the electron transport chain is the NADH:Ubiquinone oxidoreductase. 
This complex oxidises NADH, utilising ubiquinone as an electron acceptor. This 
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reaction is highly exergonic and is coupled to the translocation of protons into the 
intramembrane space of mitochondria or the periplasm in bacteria. Complex I is one 
of three proton pumps that contribute to the proton motive force (Ap). The transfer of 
protons and electrons by this complex can be represented by the following equation: 
NADH/H + Q + 4H 	 NAD + QH2 + 4H 
Where Q = ubiquinone, 	= protons taken up from the negative matrix side (or 
cytoplasmic side) of the membrane and 	= protons released into the intermembrane 
space (or periplasm). The composition of complex I varies between species but all 
contain a non-covalently bound flavin mononuleotide molecule plus up to nine iron-
sulphur clusters [Friedrich and Böttcher, 2004]. Electrons from NADH are first 
transferred to FMN before being transduced through the iron-sulphur clusters to 
ubiquinone. The large size and complicated nature of complex I has meant that so far, 
no high resolution structure of the entire assembly has been obtained. However, the 
structure of the hydrophilic domain of complex I from Thermus thermophilus has 
recently been solved at 3.3 A [Sazanov and Hinchliffe, 2006]. Low resolution 
structures (17- 34 A) have revealed that overall it forms an L-shaped structure that 
spans the inner mitochondrial membrane with peripheral regions projecting out on 
both sides (figure 1.8). The simplest type of complex I is expressed by bacteria and is 
composed of 14 subunits, homologues of which have been found in all other 
organisms studied to date (in eukaryotes, complex I contains at least 32 extra 
subunits). Seven of these "core" subunits project into the matrix and contain the 
redox co-factors and the NADH binding site. The other seven form 54 helices that 
span the inner membrane and include the site of interaction with quinones that freely 
diffuse through the membrane. This transmembrane section is also thought to play a 
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part in proton translocation, which is suspected to be driven by conformational 
changes 
1.1.5 Complex II 
Succinate-ubiquinone oxidoreductase (SQR) is often referred to as succinate 
dehydrogenase or complex II of the aerobic electron transport chain [Lancaster, 
2002]. It couples the oxidation of succinate to fumarate to the reduction of 
ubiquinone to ubiquinol. SQR is structurally and functionally related to the 
Menaquinol-fumarate reductase (QFR) which catalyses the reverse reaction 
(fumarate-succinate) in vivo, although both complexes can catalyse both reactions. 
Depending on whether the organism is respiring aerobically or anaerobically, either 
SQR or QFR will be expressed accordingly [Hagerhall, 1997]. The crystal structure 
of Escherichia coli SQR was resolved to 2.6 A [Yankovskaya, 2003]. It is composed 
of four subunits; two of which are hydrophilic in nature (a flavoprotein subunit and 
iron-sulphur subunit) and project into the cytoplasm, and two hydrophobic membrane 
spanning subunits that serve to anchor the protein into the membrane and are the site 
of interaction with ubiquinones. 
The flavoprotein subunit SdhA, has a mass of 65kDa and can be divided into two 
domains: an Flavin adenine dinucleotide-binding domain, which exhibits a Rossman-
like fold and covalently binds the FAD molecule via an Nc atom of a histidyl residue 
side chain and the flavin C8a methyl group [Mewies et a!, 19981, and also a capping 
domain. This capping domain is connected via a hinge that is able to move at least 
30° relative to the flavin domain and the active site is located at the interface between 
the two domains. The iron-sulphur subunit SdhB, consists of a [2Fe-2S] iron-sulphur 
cluster at the N-terminal domain resembling that found in plant ferrodoxins, and a C- 
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terminal domain that incorporates a [4Fe-4S] cluster and a [3Fe-4S] cluster. Together 
the FAD and iron-sulphur cofactors form a chain approximately 40 A in length, along 
which electrons are transferred from succinate to ubiquinone. The ubiquinone 
binding site (Q site) consists of residues from the SdhA, SdhB and SdhC subunits and 
is located 7.6 A from the terminal [3Fe-4S] cluster [Yanovskaya et a!, 2003]. 
Ubiquinone is ligated by a tyrosine residue and a tryptophan residue, the latter of 
which has been proposed to play a dual role in reduction to ubiquinol. Because 
electrons are transferred to ubiquinone one at a time, it is thought that the 
semiquinone is stabilised by hydrogen bonding to the tryptophan sidechain. This 
tryptophan also donates protons during reduction. There is a b-type haem located 9.8 
A from the Q site and 11.4 A from the [3Fe-4S] cluster but its role is unclear. It is 
further away and has a lower reduction potential than ubiquinone so electron transfer 
via this haem would be less favourable and much less likely to occur than direct 
transfer from the [3Fe-4S]. Also it is not found in the E. co/i QFR enzyme and 
mutagenesis experiments suggest that it is not essential for quinone reduction 
[Makiashina el a!, 2001]. After reduction by complex II, ubiquinol then diffuses 
through the plasma membrane where it can donate electrons to other components of 
the electron transport chain. 
1.1.6 Complex III 
Complex III is the Cytochrome bc 1 complex which like complex I, also doubles as a 
proton pump. It couples the transfer of electrons from ubiquinone (reduced by 
complex I and complex II) to mobile cytochrome c to the translocation of protons 
across the mitochondrial membrane [Wikstrom et al, 1981]. Again composition of 
the complex varies between organisms but all possess three subunits containing two 
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Figurel.9 - The "Qcycle" 
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"Q- cycle" - Schematic of complexlll redox centres and binding sites. There are two quinol binding 
sites; Q° which is the site of quinol oxidation, and Q, which is the site of quinine reduction. One 
electron from ubiquinol (QH2) is transferred to cytochrome c (red) via an iron-sulphur cluster (yellow 
and a c-type haem (orange), while the other is transferred to the Q, site via two b-type haems (pink), 
where it is used in the reduction of ubiquinone (Q). To complete reduction of ubiquinone, two 
molecules of Ubiquinol (QH 2) are consumed. Therefore each complete cycle uses two QH 2, and results 
in production of one reduced ubiquinone, two reduced c-ytochrome c and translocation offour protons 
across the membrane. 
b-type haems, cytochrome c 1 and a "Rieske" [2Fe-2S] iron-sulphur cluster [Iwata et 
a!, 1998]. The crystal structure of the 11-subunit bovine heart mitochondrial bc 1 was 
resolved to 2.8 A. The complex spans the width of the inner mitochondrial membrane 
and contains peripheral subunits that project out on both sides. The intermembrane 
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peripheral region contains the iron-sulphur cluster and cytochrome c1, and is also the 
site of interaction with soluble cytochrome c. The coupling of exergonic electron 
transfer to the translocation of protons has been proposed to occur by the "Q cycle" 
mechanism (figure 1.9) [Trumpower and Gennis, 1994]. There are two separate 
quinol binding sites; one for the oxidation of ubiquinol (Q0 site) and one for the 
reduction of ubiquinone (Qt site). Ubiquinol undergoes a two-electron oxidation at Q° 
in a bifuricated manner. One electron is transferred to the [2Fe-2S] cluster, then to 
the c3 haem before being accepted by soluble cytochrome c. This electron transfer is 
accompanied by the release of 2 protons to the intermembrane space. The other 
electron is transferred to the Q j site via the two b-type haems (bL and bH)  where it 
reduces ubiquinone. A second molecule of ubiquinol has to enter the Q cycle in order 
complete reduction along with the uptake of 2 protons from the matrix. Therefore, the 
complete Q-cycle oxidises two ubiquinol molecules and consumes two protons. This 
results in the production of two reduced cytochrome c and one reduced ubiquinol 
while also translocating 4 protons into the intermembrane space . This can be 
summed up as: 
2QH2 + 2Cytc0 + 2H 	QH2 + 2Cytc red + 4H 
Reduced cytochrome c then goes on to donate electrons to complex IV. 
1.1.7 Complex IV 
Complex IV is the Cytochrome c oxidase complex and like I and III it is a proton 
pump contributing to the proton motive force. It catalyses the reduction of the 
terminal electron acceptor oxygen, converting it to water. Crystal structures of both 
prokaryotic and eukaryotic forms of complex have been obtained and although they 
differ in size and composition, all contain two catalytic subunits [Iwata et al, 1995] 
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[Yoshikawa et a!, 1998]. Subunit I contains haem a plus a binuclear centre containing 
haem a3 and a copper ligated by three histidine residues (CUB) which is the site of 
oxygen reduction. Subunit II projects out into the intermembrane space/periplasm 
and contains another copper centre (CuA) which is the site at which cytochrome c 
docks and donates electrons to the complex. Electrons are transferred between 
centres in the following way: 
Cytochrome c - CUA - haem a - haem a3: CUB - 02 
When the binuclear centre is in the reduced state it binds oxygen which then exists 
briefly as a ferrousoxy species before forming a bridging peroxoide between haem a3 
and CUB. A series of electron transfers breaks the 0-0 bond and results in the 
production of two water molecules, accompanied by the translocation of four protons 
[Michel, 1998]. It is thought that these protons are pumped into the intermebrane 
space through the "D-channel" which is so called due to its being lined by negatively 
charged aspartate residues. 
1.1.8 Complex V: ATP synthase 
The ATP synthase complex couples the movement of protons down the 
electrochemical gradient (Aj.H) with the production of the cell's energy currency 
ATP [C. Gibbons et al, 2000]. The complex can be divided into two regions - a 
globular catalytic region (17 1 ) that projects out into the mitochondrial matrix and a 
proton-translocating intermembrane region (F 0). These two regions are connected by 
a "stalk" which is composed of three subunits. One of these subunits (the y subunit) 
projects into the catalytic region and is surrounded by six alternating a and 0 subunits. 
The P subunits contain the catalytic nucleotide binding sites, making three in total per 
ATPase. The production of ATP is thought to occur by the "binding change 
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mechanism" [Boyer, 1993]. This postulates that the three nucleotide binding sites 
have different affinities for the ADP substrate. The "open" site has the lowest 
affinity, the "loose" site is able to bind ADP reversibly and the "tight" site binds ADP 
in such a way that ATP is formed spontaneously from bound ADP and an inorganic 
phosphate. The only way protons can pass through the inner membrane is through the 
central channels of the ATPases. The energy released as protons rush through to the 
more negative matrix powers rotation of the catalytic region of the ATPase. Rotation 
occurs in 1200  steps and every complete 3600  turn takes each of the three ADP 
binding sites through all of the aforementioned binding states [Yasuda et a!, 1998]. 
Therefore, each rotation step results in the production of one ATP molecule. 
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1.2 Anaerobic electron transport chains 
In environments where there is no oxygen present many organisms are able to respire 
utilising alternative electron acceptors. These include inorganic species such as 
nitrate (NO3 ), sulphate (S042 ), ferric iron (Fe 3 ) and manganese (Mn 4 ) as well as 
organic compounds such as fumarate and trimethylamine oxide (TMAO). Certain 
eukaryotes such as ciliates and fungi even possess anaerobically functioning 
mitochondria that contain the same complexes found in aerobic mitochondria, 
although electron transfer is coupled to the reduction of NO 3 to nitrous oxide [van 
Hellemond et al, 20031. Amongst bacteria, anaerobic electron transport chains vary 
depending on the terminal electron acceptor used. Figure 1.10 shows an example of a 
bacterial anaerobic electron transport chain where fumarate is the terminal electron 
acceptor. Fumarate is commonly used, which is not surprising as it is an intermediate 
formed during the citric acid cycle so the organism does not have to depend on its 
availability in the immediate environment. Instead of coupling the oxidation of 
NADH and FADH2 to the generation of the electrochemical gradient (pAH), this 
chain involves complexes that catalyse oxidation of formate and molecular hydrogen. 
Instead of ubiquinones, lower potential menaquinones act as electron 
acceptors/donors during anaerobic electron transport [Wistance and Terelfall, 1968]. 
The reason for this may be that most alternative terminal electron acceptors have 
lower potentials than oxygen, so the lower potential menaquinones ensure that 
electron transfers between redox centres are exergoninc. Electrons from the oxidation 
of formate and H2 are transported by menaquinols to the Quinol fumarate reductase 
complex (QFR), where they are used in the catalytic reduction of fumarate to 
succinate. Oxidation by formate dehydrogenase and hydrogenase generates protons 
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Schematic qfpart of an anaerobic electron transport chain. Oxidation offormate by the formate dehydrogenase complex and 
also ''2  by hydrogenases, produce electrons which are then transferred tofumarate, (the terminal electron acceptor) via the 
quinol/fumarate reductase complex ('QFR). The hydrogenases release protons into the periplasm thus maintaining the proton 
motive fbrce 'p. m.fu. A TP is generated by the harnessing oJthe p. m.f by A TP svnthases as in aerobic electron transport. 
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a proton motive force. As in aerobic electron transport chains, this drives synthesis of 
ATP by ATPases. 
1.2.1 Formate dehydrogenase 
Formate dehydrogenase isolated from Escherichia coli is synthesised from a single 
polypeptide that can be divided into four domains. It has a mass of 79kDa and 
contains three redox co-factors; a selenocysteine, a molybdenum atom ligated by two 
molydopterin guanadine dinucleotide (MGD) molecules, and a Fe 4S4 cluster 
[Bonnington et a!, 1997]. This enzyme catalyses the oxidation of formate to CO2 
while releasing a proton into the periplasm, thus maintaining the proton gradient 
across the membrane. The active site molybdenum:MGD cofactor is tightly bound to 
the protein via hydrogen bonding, salt bridges and van der Waals interactions with 
domains II, III, and IV. Of the 35 H-bonding interactions, 23 are conserved in other 
formate dehydrogenases of the same type. In both the oxidised and the reduced forms 
of the enzyme, Mo is ligated to four S atoms of the two MGD's plus the 
selenocysteine. Prior to catalysis, the oxidised Mo centre displays trigonal prismatic 
geometry. However when it becomes reduced by the oxidation of formate, the 
coordination geometry is square pyramidal and Mo sits -0.4A above the equatorial 
plane. The oxidation of the Mo centre as electrons are transferred from the active site, 
results in the breakage of an H-bond between SeCys and a histadine residue causing a 
proton to be released into solvent. Electrons are transferred to the iron sulphur cluster 
one at a time and shuttled to an acceptor, perhaps menaquinone, although the 
physiological acceptor is not at this moment known. It is possible that it does not 
reduce menaquinone directly but instead donates electrons to an intermediate carrier. 
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However, for the purpose of assaying enzymatic activity, the artificial electron 
mediator benzyl viologen can play this role in vitro. 
1.2.2 H2 Hydrogenase 
Hydrogenases couple the oxidation of molecular Hydrogen to the reduction of 
fumarate or other terminal electron acceptors. 
H2 	2H + 2e 
They are also able to catalyse the reverse reaction and are thought to play a role in the 
clearing of excess electrons produced during fermentative processes [Rousset et al, 
1998]. The structure of the NiFe hydrogenase from Desulfovibrio vulgaris was 
resolved to 1.8A [Higuchi et a!, 1997]. It has a molecular weight of 91kDa and 
possesses two [Fe 4S4] clusters, one {Fe3 S4] cluster and a Ni atom closely associated 
with an iron atom forming a heterobinuclear active site. The Ni atom is coordinated 
by four S atoms from cysteine residues, two of which also coordinate Fe, forming 
bridges between the two atoms. The Ni atom is coordinated with square pyramidal 
geometry whereas the coordination geometry around the Fe atom centre displays 
distorted octahedral geometry. This enzyme also incorporates a Mg atom but at 
present its role in enzyme function is not known. 
1.2.3 Quninol fumarate reductase 
As previously mentioned, quinol:fumarate reductase (QFR) is very similar to 
succinate:quinol reductase (SQR) or complex II of the aerobic electron transport 
chain. It contains four subunits designated FrdA, FrdB, FrdC and FrdD. These two 
enzymes only really differ from each other in their membrane-spanning regions, 
probably due to the fact that they interact with different types of quinone [Lancaster, 
2001]. Under aerobic conditions SQR donates electrons from the oxidation of 
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succinate to ubiquinone, reducing it to ubiquinol. Under anaerobic conditions, 
menaquinol donates electrons to QFR which are then used in the reduction of 
fumarate to succinate. In addition, SQR contains a b-type haem cofactor and QFR 
does not. These factors along with differences in the measured potentials for the 
redox centres (including FAD) determine whether the enzyme is biased towards 
succinate oxidation or fumarate reduction. Despite the differences, the active site and 
residues surrounding the iron-sulphur clusters are conserved in sequence across 
SQR's and QFR's of different species. The crystal structure of Escherichia coli 
fumarate reductase with two molecules of menaquinone bound was resolved to 3.3 A 
in 1999 [Iverson et al, 1999]. In addition to the covalently bound FAD and three iron-
sulphur clusters, it contains two quinol binding sites in the membrane-spanning 
region, designated Qp and QD.  The Qp site is distanced 8.2 A from the [3Fe4S] cluster 
and in a reversal of the electron transfer pathway in SQR, electrons are transferred 
from bound menaquinone at Qp to FAD at the active site via the iron-sulphur clusters 
where they are used in the catalytic reduction of fumarate to succinate. All edge to 
edge distances between redox centres are under 14 A, facilitating fast electron 
transfer. The function of the QD  site is unclear. It is over 25 A away from the Qp site 
making it unlikely that it participates in any electron transfer pathway. It was 
proposed to have a structural role but mutagenesis studies do not appear to support 
this [Iverson et a!, 2002]. 
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1.3 Shewanella frigidimarina 
The genus Shewanella contains diverse species of Gram-negative bacteria that are 
found mostly in marine environments. The genus includes a bioluminescent species 
Shewanella hanedai [Jensen et al, 1980] a tetrodotoxin producing species Shewanella 
alga [Khashe and Janda, 1998] and Shewanella benthica which inhabits the gut of 
marine crustaceans [Bowman et a!, 1997]. 
The first species to be discovered was originally obtained from rancid butter by Derby 
and Hammer in 1931 who called it Achromobacter puirefaciens. Over the years 
since, it has been re-classified several times, until 1997 (prior to which it was known 
as S. putrefaciens) when it was designated Shewanellafrigidimarina [Bowman et al, 
1997]. There have been cases when S. frigidimarina has been known to be 
pathogenic to humans in the form of soft tissue infections, cellulitis and septicaemia. 
Cases are relatively few however and have occurred almost exclusively in patients 
that were immunocompromised by existing illness especially liver disease. 
Shewanellafrigidimarina are rod-shaped and may be curved or straight. The bacteria 
are psychrotrophic and grow between <0-27° centigrade but optimally at 23°. They 
are able to ferment D-glucose under anaerobic conditions and can utilise inorganic as 
well as organic sources of nitrogen [Bowman et al, 1997]. 
They respire aerobically but are facultative anaerobes known to be capable of utilising 
many different electron acceptors during anaerobic respiration. These include ferric 
compounds [Loveley and Philips, 1986], manganese oxide, molybdenum oxide, 
nitrate and elemental sulphur [Moser and Nealson, 1996]. 
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1.3.1 Flavocytochrome C3 
When growing under anaerobic conditions with fumarate present, Shewanella 
frigidimarina abundantly produces a unique soluble fumarate reductase, 
Flavocytochrome C3 [Gordon et a!, 1998]. The fact that Fcc3 is soluble enables easy 
extraction and purification of the active enzyme, making it ideal for the study of 
electron transfer mechanisms in redox proteins. Like QFR, Fcc3 catalyses the 2-
electron reduction of fumarate to succinate during anaerobic respiration. Fcc 3 is 571 
amino acids in length with a mass of 63.8kDa and is synthesised as a single 
polypeptide encoded by the fccA gene [Pealing et a!, 1992]. Its synthesis is induced 
by anaerobiosis and thought to be regulated by the EtrA gene (electron transport 
regulator A). This protein is homologous to the DNA-binding protein Fnr from E.coli 
[Guest, 1992], which is a member of the CRP family of transcriptional regulators. S. 
frigidimarina strains deficient in this gene do not grow on fumarate [Saffarini and 
Nealson, 1993]. Expression of the fccA gene appears to be regulated at the 
transcriptional level in response to the redox potential of terminal electron acceptors 
present [Gordon et al, 1998]. It is down-regulated when oxygen is present and also if 
TMAO or nitrate is present, although in the case of the latter two to a lesser extent. 
This is presumably because components of alternative electron transport chains are 
synthesised instead when these substrates are present. The signal sequence 
immediately upstream from the N-terminus of the protein enables transportation of 
Fcc3 to the periplasm. When this sequence is disrupted or removed Fcc 3 is still 
expressed, but located in the cytoplasm and cells are unable to utilise fumarate as a 
terminal electron acceptor [Gordon et al, 1998 ]. 
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1.3.2 Electron transport in Shewanella 
In order for S. frigidimarina to respire on fumarate, Fcc3 has to be constantly supplied 
with electrons. It has been proposed that it may receive electrons from the 
periplasmic tetrahaem cytochrome c, CymA. This 21 kDa protein is anchored to the 
periplasmic membrane and is a member of the NapCfNirT family of proteins that are 
known to transfer electrons from quinols in the membrane to periplasmic reductases. 
Experiments carried out previously in this laboratory have shown that CymA is able 
to directly transfer electrons to Fcc 3 in vitro [Schwalb et a!, 2002], although it is 
possible that in vivo, electrons are transferred indirectly by way of an as yet 
unidentified electron carrier. Figure 1.11 shows a possible electron transport chain 
that includes CymA and Fcc3 and utilises fumarate as a terminal electron acceptor. It 
has been hypothesised that CymA is able to interact with different terminal reductases 
that are expressed depending on which terminal electron acceptors are present. This 
has been supported by experiments that demonstrated that strains of S. oneidensis 
MR-i deficient in CymA were no longer able to respire using nitrate, fumarate, Mn 4 , 
Fe 3+ and DMSO [Myers and Myers, 1997] [Schwalb et al, 2003]. 
-30- 
Outer membrane 





involved in other 
me bolic pathways 
H2 	 H 
fumaraic 
C- 
• I I S 511 • I I I I S SI S I • 	II SI SI I S S • • I 
MQ T 
MQh 	
Cy mA 	 _C
MQFi 








Hypothetical anaerobic electron transport chain that knight be employed during respiration upon fumarae by Shewanella. Electrons from 
hydrogenases are transferred to ubiquinol which then tramjèrs them to a membrane-bound tetraheme cymA, before they are transferred  to the 
soluble fumarate reductase and used in the catalytic reduction offumarate to succinate. Ills thought that CvmA partakes in more than one 
anaerobic electron transport chain as it is able to donate electrons to a variety of different terminal reductases. 
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Figure 1.12 Global structure of Flavocytochrome c3 
Global structure of Flavocytochrome c3. The cytochrome domain which incorporates four c-type haems 
is shown in red, the Flavin domain is shown in yellow and the mobile clamp domain is shown in blue 
1.4 Crystal structure of Fcc 3 
The crystal structure of S. frigidimarina Fcc3 was solved in 1999 to 1.8A (see Fig 
1.12) [Taylor el al, 1999]. Structures were also obtained for Fcc 3 from S. putrefaciens 
MR-i (which shares 59% sequence similarity with S. frigidimarina Fcc3) and for iron-
induced Fcc3, an isoform of Fcc 3 [Leys et a!, 1999] [Bamford et al, 1999]. Fcc3 is 
functionally and structurally related to L-aspartate oxidase which catalyses the 
oxidation of L-aspartate to iminoaspartate but is also able to reduce fumarate to 
succinate [Mattevil et al, 1999]. It can be divided into three functionally distinct 
domains; a tetrahaem cytochrome domain, flavin domain and clamp domain. Unlike 
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QFR, Fcc3 is not bound to the cytoplasmic membrane and exists freely in the 
periplasm. Also, it uses c-type haems to transfer electrons to the active site instead of 
iron-sulphur clusters. Previous studies of fumarate reduction kinetics have shown that 
Fcc3 is generally a unidirectional fumarate reductase [Turner et a!, 1999] as it 
catalyses the oxidation of succinate at a slow rate compared to QFR, which catalyses 
succinate oxidation and fumarate reduction with similar efficiencies. 
1.4.1 Cytochrome domain 
The cytochrome domain is composed of the first 100 residues from the N-terminus 
(after removal of the signal peptide) and incorporates four c-type haem groups (figure 
1.13 a) that are bis-His axially ligated and form a molecular "wire" 40 A in length 
along which electrons are transferred [Taylor et a!, 1999]. Studies have indicated that 
Fcc3 most likely receives electrons from the small membrane-bound tetrahaem CymA 
[Schwalb et a!, 2002], instead of receiving them from the quinone pool (constrained 
within the membrane) directly. Electrons are then transferred by the haems to FAD 
(Flavin adenine dinucleotide) at the active site. 	The rate of electron transfer 
decreases with distance and in order for transfer to be fast enough to be of use for 
biological catalysis, redox centres are generally required to be less than 14 A apart 
[Page et a!, 1999]. The short distances between the haems (figure 1.13) and their 
orientation relative to each other optimise fast electron transfer to FAD [Smith et a!, 
2006] and experiments have shown that it is not the rate-limiting factor [Jones et a!, 
20001 for fumarate reduction. Reduction potentials (figure 1.13) for each of the four 
haems have been determined by redox potentiometry [Doherty, 1999] and protein film 
voltammetry [Turner et al, 1999]. 
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Haem 1 	-146 mV 
Haem 11 	-196 mV 
Haem III 	-lO2mV 






Arrangement of redox cofactors in Fcc3. Edge to edge distances (pink dashes) are indicated. Haems 
are numbered I-JV and their midpoint reduction potentials are listed. The short distances between 
haems facilitate fast electron transfer to the active site FAD. 
There is no conclusive evidence that the haems in the cytochrome domain of Fcc 3 are 
always reduced in a particular order. It has been proposed that the purpose of haems I 
- III is to maximise electronic coupling between the electron donor to Fcc3 and FAD 
at the active site, particularly as all three are located at the surface of the protein and 
exposed to solvent. Mutation of His 61 (the axial ligand of haem IV) to methionine 
and alanine resulted in five-fold or 10-fold lower k eat values respectively compared to 
wild-type [Rothery et a!, 2003] . Solvent isotope studies of H6 1 M and H6 1 A 
revealed that electron transfer had become rate-limiting although there is no real 
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change in the midpoint reduction potential of haem IV. Studies of a closely related 
flavocytocbrome Ifc3, also expressed by S. frigidimarina [Butt et a!, 2000], [Pessanha 
et a!, 2003], have led to the suggestion that two electron transfer pathways each 
donate an electron to FAD either in parallel, or after first converging, ensuring fast 
electron delivery to the active site. However, the crystal structure disproves this so it 
is proposed that haems I - III serve only to maximise electron transfer to haem IV and 
subsequently FAD at the active site [Rothery et a!, 2003]. 
1.4.2 Flavin domain 
The flavin domain consists of residues 111-364 and 5 03 -5 71 [Taylor eta!, 1999], and 
forms part of the active site (the rest is composed of residues from the clamp domain) 
that includes FAD bound via non-covalent interactions. It shares a high level of 
sequence similarity to the flavin subunits of Escherichia coil and Woiineila 
succinogenes fumarate reductases [Iverson et al, 1999] [Lancaster et a!, 1999] and 
exhibits the typical Rossman-like fold. Despite the differences between Fcc 3 and the 
membrane-bound fumarate reductases, the architecture of the active site is highly 
conserved across all fumarate reductases suggesting a common catalytic mechanism. 
Electron transfer from FAD to fumarate is particularly favoured in Fcc3 because FAD 
has a much lower reduction potential (-1 52mV) than the fumarate-succinate couple 
(30mV at pH 7.0) [Turner et a!, 1999]. However, this lower potential does not favour 
efficient catalysis of succinate oxidation (reverse direction) which only occurs at a 
low rate with a k cat of - 1.s-1 [Moysey, 2001]. The reason for this low potential is the 
non-covalent nature of FAD binding. As previously mentioned during discussion of 
E. coil QFR, FAD is bound covalently via a histidyl residue. Substitution of His 44 
from the flavin subunit of QFR results in the loss of covalent linkage to the FAD 
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molecule, although it still remains tightly bound through non-covalent interactions 
with the protein matrix. This has the effect of knocking out succinate oxidation 
activity yet the enzyme retains significant fumarate reductase activity. Therefore the 
way in which the FAD molecule is attatched to the protein appears to determine the 
directionality of catalysis. [Blaut eta!, 1989]. 
1.4.3 Clamp domain 
The clamp domain is made up of residues 365-502. In addition to forming one side of 
the active site (figure 1.14 a), the clamp domain is capable of movement, which has 
been postulated to allow substrate access/product release to and from the active site 
[Taylor et a!, 1999]. Comparison of the crystal structure of Fcc 3 in the "closed" 
conformation (shown previously in figure 1.12) with the crystal structure of an 
isozyme of Fcc 3 - iron-induced flavocytochrome C3 (iFcc3) - obtained in the open 
conformation [Bamford et al, 1999], revealed that the clamp domain moves 14° 
towards the cytochrome domain, opening a gap at the active site. When the clamp is 
closed, steric constraints cause fumarate to be held in a twisted conformation at the 
active site, an important aspect of the catalytic mechanism which will be discussed in 
section 1.4.4. In order to ascertain the importance of clamp domain mobility to 
enzyme activity, Fcc3 was engineered so that the clamp domain was immobilised in 
the closed conformation [Rothery et al, 2004]. This was done by substituting two 
amino acid residues with cysteines (alanine 251 from the cytochrome domain and 
serine 430 from the clamp domain) which under oxidising conditions formed a 
disulphide bridge, locking the two domains together in a fixed position. This bridge 
could be broken by the addition of dithiothreitol allowing comparison of fumarate 
reduction rates between "mobile" and "fixed" Fcc3. It was found that the unbridged 
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double mutant retained approximately 63% of the activity of wild-type Fcc 3 . When 
the disulphide was formed, activity dropped to about 25% of that observed in wild-
type. It was concluded that although clamp domain movement may optimise 
enzymatic activity, it does not appear to be essential for catalysis of fumarate 
reduction [Rothery et al, 2004]. 
1.4.4 Catalytic mechanism of fumarate reduction 
Figure shows the crystal structure of the active site of Fcc 3 with a malate-like 
molecule bound [Taylor et al, 1999]. The four carbon atoms of the substrate have 
been labelled I - 4 to illustrate their relative orientation to active site residues. 
Hydrogen bonding interactions and steric constraints imposed by two nearby 
methionine residues (Met 236 and Met 375) cause the Cl carboxylate to be twisted 
out of plane. This combined with the positive environment (His 504, Arg 544) 
surrounding the C4 carboxylate, polarises the C2 - C3 double bond (figure 1.14 b). 
As a result, significant positive charge is conferred on C2, facilitating nucleophilic 
attack by N5 of the flavin alloxazine ring and hydride transfer (figure 1.14 b). To 
complete formation of succinate, a proton is abstracted from arginine 402 [Doherty et 
al, 2000]. Arg 402 is reprotonated after each reduction by Glu 378, a residue that 
takes part in the proposed "proton pathway" [Pankhurst, 2002], thought to be the rate-
limiting factor in fumarate reduction. Fcc3 follows Michaelis-Menten kinetics and 
converts fumarate to succinate with a k cat of 509 ± 15 s and a Km of 25 ± 2 j.tM 
[Doherty, 1999]. The k cat represents the number of molecules of fumarate reduced to 
succinate by a single enzyme molecule per second. The K m is the Michaelis constant, 
which is the concentration of substrate when activity is 50 % of the maximum and is 
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a) Crystal structure of active site of Fccj complexed with fumarate. The carbons of the substrate are 
numbered 1-4 to indicate their relative orientation to the active site residues. The pink arrows indicate 
the proton pathway, which continually reprotonates R402 and is the rate-determining step of catalysis 
H-bonds are shown as blue dashes. b)Polarisation of the double bond infumarate is aided by twisting 
of the Cl carboxylate and the influence ofpositive residues around C4 (His 504 Arg 544). The two 
electron reduction offumarate is achieved by hydride transferfromflavin N5 tofumarate C2followed 
by proton transfer from Arginine 402 tofumarate C3. 
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a measurement of how readily the enzyme-substrate complex forms. It is thought 
that hydride transfer occurs before proton transfer. The malate-like molecule is a 
hydroxylated intermediate which arises from nucleophilic attack by a water molecule 
under oxidising cyrstallisation conditions (hydride transfer cannot occur). The 
geometry of this intermediate suggests it has not yet been protonated suggesting that 
fumarate reduction occurs in two steps. 
1.4.5 Arginine 402 
Often the role of an active site acid/base is carried out by a histidine. However, when 
either His 365 or His 504 were substituted with alanine, the enzyme retained 
significant activity, approximately 10% of that observed for the wild-type enzyme. 
This suggests that while these histidines play a role during catalysis of fumarate 
reduction, they are not essential for it to occur. Mutagenesis experiments that 
replaced arginine 402 suggested that this residue was the active site acid. Subsequent 
kinetic assays of these engineered forms of Fcc3 showed that activity was completely 
knocked out when Arg 402 was substituted with alanine, but that residual activity was 
observed for substutions with lysine or tyrosine albeit at levels 103 - 104 times lower 
than wild-type [Mowat et al, 2002]. This implies that these residues are also capable 
of acting as the active site acid. The two positions that each NH 2 of the guanidinium 
group from arginine 402 occupies are denoted A and B in figure 1.15 and reflect the 
dual role that arginine has in catalysis. The NH2 at position A is part of the proton 
delivery system that transfers protons to the buried active site via residues from the 
surface exposed to solvent. It is distanced 3A from C3 of the substrate - ideally 
placed to donate a proton during catalysis. The NH 2 in position B forms H-bonding 
interactions with a sidechain amide of Glu 363 and an 0 atom from the C4 carboxyl 
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Figure 1.15 Position of arginine 402 relative to substrate 
Crystal structure showing positioning of the guanidinium group of Arginine 402 relative to bound 
fumarate. The NH2 group at position A donates a proton to C3 offurnarate to complete reduction to 
succinate. The NH, at position B stabilises the build-up of negative charge during the transition state. 
Arginine 402 thus acts as both a Bra nsted and a Lewis acid during catalysis. 
of ftimarate, stabilising the build-up of negative charge that occurs during the 
transition state thus acting as a Lewis acid and increasing the rate of the reaction. The 
tyrosine and lysine residues occupy a similar position in the active site as that of 
arginine in the WT enzyme. They are distanced 3.2A and 3.7A from C3 of fumarate 
respectively and so are able to transfer a proton and function as a Brønsted acid 
though less efficiently than arginine. The structures for R402A and R402K show a 
water molecule at position B, but this is not seen in R402Y. As the water molecule is 
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unable to stabilise the transition state, the arginine mutants cannot act as a Lewis acid, 
another reason that reduction rates are so low compared to the wild-type enzyme. 
1.5 Project aims 
1.5.0 Determination of substrate range 
The kinetics of fumarate reduction by Fcc3 have previously been thoroughly 
investigated [Doherty, 1999]. [Pankhurst, 2002]. The purpose of this project is to 
determine whether Fcc3 is able to catalyse the reduction of similar compounds 
(fumarate derivatives) with any degree of efficiency. The ability of Fcc 3 to reduce or 
bind to particular chemicals could provide a great deal of information about the 
chemistry and morphology of the active site as well as explore its catalytic potential. 
Prior work demonstrated that 2-methylfumarate could bind to Fcc 3 and act as an 
inhibitor of fumarate reduction [Moysey, 2001]. However, at the time these studies 
were done, 2-methylfumarate was not thought to act as a substrate. 
1.5.1 Engineering of Fcc3 
An obvious question is whether the alteration of the Fcc 3 active site would alter the 
enzyme's substrate specificity. Previous studies of Shewanella oneidensis MR-i 
(closely related to Shewanella frigidimarina) revealed that it expresses four novel 
proteins that share high sequence similarity to Fcc3 [Bilsland, 2004]. These enzymes 
were denoted Fcc54, Fcc56, Fcc63 and Fcc342. Unlike Fcc3, these flavocytochromes 
consist of two subunits instead of a single polypeptide. They are encoded by two 
separate genes adjacent to each other in the genome for example; fccA54, which 
encodes the flavin domain and JècB54 which encodes the tetrahaem cytochrome 
domain for Fcc54. Molecular modelling and sequence alignment studies predicted 
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that these flavocytochromes may function as monocarboxylate reductases. However, 
so far no assays of the enzyme's activity in this capacity have yet been carried out. 
This is due to the fact that so far no intact enzyme containing both subunits has yet 
been purified. Many of the residues predicted to make up the active site of these 
putative enzymes appear to be conserved in Fcc3 and in other monocarboxylate 
reducing enzymes from other organisms. Examples include a 50 kDa periplasmic 
flavoprotein purified from Geobacter sulfurreducens AM-1 [Galouchko et al, 1996], 
and a 52 kDa periplasmic flavoprotein which is the product of the fccA gene from 
Wolinella succinogenes [Gross et al, 2001]. The Geobacter flavoprotein was also 
found to be able to reduce acrylate, crotonate and pentenoate [Mikoulinskaia et a!, 
1999]. For this reason, mutagenesis experiments that substituted active site residues 
were carried out in order to determine if Fcc3 could be engineered to act upon 
substrates not reduced by the wild-type enzyme. 
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2.0 Molecular biolgy 
Recombinant Flavocytochrome C3 was prepared using the pEGX 1 IEG301 expression 
vector system (pEGX 1 plasmid - pMMB503EH fcc 3 with signal sequence, EG301 - 
Shewanellafrigidimarina NCIMB400 StrR,  Afccahp Kn1R)  [Overbye et a!, 1995] 
[Gordon et a!, 1998]. Bacterial strains were stored long term as DMSO stocks (-80 
°C). 
2.0.1 Site-directed mutagenesis 
Fcc3 mutants were generated by in-vitro site-directed mutagenesis using the 
QuikChange XL system (Stratagene®). Mutagenic primers ( shown in appendix 4) 
were designed by Dr. Caroline Miles and supplied by Invitrogen. The primers were 
annealed to thermally denatured double stranded plasmid DNA (pEGX 1 ) containing 
the target gene —fcc 3. Pfu Turbog DNA Polymerase incorporated the mutation as it 
extended the mutagenic primers and replicated the plasmid, resulting in nicked 
circular daughter strands. The parental plasmid DNA is methylated so it was 
digested by the addition of Dpn I endonuclease which specifically targets methylated 
DNA. Because the daughter strands are not methylated, they remained intact and 
were transformed directly into XL 10-Gold ultracompetent cells. Once transformed, 
cellular enzymes repair the nicks in the DNA to produce the new plasmid containing 
the mutation. 
2.0.2 Cell Transformation 
Cell transformations were carried out by the direct addition of the plasmid DNA to 
chemically competent cells (XL IO-Gold - Stratagene®). The mixture was incubated 
on ice for 45 minutes before being heat-shocked at 45°C for 60 seconds. The cells 
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were then incubated on ice for five minutes before the addition of 750 tl Luria Broth 
after which, cells were incubated while shaking at 37°C for One hour. The plasmid 
contains streptomycin and kanamycin resistance genes so the cells were then plated 
out on to agar plates containing 25.tgIml streptomycin and 50 pg!ml kanamycin in 
order to select for transformants. The plates were incubated overnight at 37°C and 
single colonies were picked and then grown in 5m1 LB to an OD of approximately 0.6 
before being pelleted in preparation for plasmid purification. Plasmids were purified 
using the QiAprep® miniprep kit (QIAGEN). Purified plasmids were sequenced 
(sequencing service at the Institute of Cell and Molecular biology at the University of 
Edinburgh - ABI 3100 genetic analyser) to ensure that the correct mutation was 
present. The plasmids were then transformed into competent SM1O E. coli cells using 
the same method as before. The reason for this transformation is that the plasmid has 
to be transferred finally to S. frigidmarina due to the fact that E. coli cannot 
incorporate c-type haems into proteins so are no use for expressing Fcc 3 . SM1O cells 
are able to transfer plasmid DNA to S. frigidimarina via bacterial conjugation. 
2.0.3 Bacterial conjugation 
Conjugation and transfer was achieved by mixing cultures of both bacteria (with a 
ratio of 10:1 S. frigidimarina:E. co/i SM1O) before pipetting 50 tl of the mixture on 
to a nitrocellulose membrane on top of minimal agar. The plates were incubated 
overnight at 23°C (to favour growth of S. frigidimarina) after which the bacteria were 
removed from the membrane by vortexing in I ml LB. The cells were then pelleted 
by centrifugation and resuspended in fresh LB (1 ml) before a small amount was 
added to agar plates containing rifampicin (to select for S. frigidimarina), 
streptomycin and kanamycin (to select for plasmid). After incubation at 23°C for 
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about 48 hours, single colonies of S. frigidimarina containing mutant Fcc3 could be 
picked for large scale growth of cells and expression of protein. 
21 Bacterial growth 
All cultures were grown in Luria Bertani high salt media containing: 
Bacto tryptone 	lOg/i 
Yeast extract 	5g/l 
NaCl 	 lOgIl 
Before use, media was sterilised in autoclave. Shewanella frigidimarina cells were 
inoculated into 75ml starter flasks supplemented with kanamycin (50 jtg/ml, sigma) 
and streptomycin (25 ig/m1, sigma), previously sterilised with a 0.2 tm syringe filter 
(sartorius). Cells were grown overnight in an Innova 4330 shaker (180 rpm) at 23°C. 
5m1 of starter culture was inoculated into 1 litre flasks (containing 500ml media plus 
antibiotic at concentrations stated above) and grown in shaker at 23°C for 
approximately 8 hours (or optical density of at least 0.6 at 600nm). Overexpression of 
Fcc3 was then induced by addition of 500 t1 IPTG (isopropyI-3-D-
thiogalactopyranoside (Europa bioproducts), 250 mg/ml) and left overnight 
(remaining in shaker at 23°C). 
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2.2. Protein Purification 
Buffers 
TRIS 	10mM TRIS (Acros organics) 
10mM NaCI (Fisher scientific) 
pH adjusted to 8.4 with HC1 
Buffer A 10mM MOPS (Sigma) 
pH adjusted to 7.8 with NaOH at 25°C 
Buffer B 10mM MOPS (Sigma) 
0.5M NaCl 
pH adjusted to 7.8 with NaOH at 25°C 
2.2.1 Harvesting of cells and lysis 
Cells were pelleted by centrifugation at 8,000 rpm (Sorvall RC-5B) for 20 minutes. 
Cells were suspended in buffer (10mM TRIS, pH 8.4) and broken open by sonication 
(Sanyo soniprep 150) on ice at 10 microns for six 20 second bursts (20 seconds rest in 
between, left for five minutes after 3rd burst to prevent overheating). The suspension 
was then centrifuged at 20,000 rpm for one hour to remove cell debris. Fcc 3 was 
purified from supernatant over a four-step process. 
2.2.2. Ammonium sulphate cut 
Ammonium sulphate (Fisher Scientific) was added to supernatant to give a final 
concentration of 243g!l (40%) and left on a magnetic stirrer for 2 hours at 4°C. The 
mixture was then centrifuged at 20,000 rpm for 20 minutes. Fcc3 is not precipitated at 
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this concentration so remains in supernatant which is subsequently dialysed (0) in 4 
litres 10mM TRIS buffer pH 8.4 to remove salt. 
2.2.3. Anion exchange, DE-52 
A 1 50m1 column of DE-52 (Whatman) was equilibrated with 5 column volumes of 
10mM TRIS pH 8.4 before loading protein. Bound Fcc3 is seen as a dark red band at 
the top of the column. The column was washed through with 10mM TRIS pH8.4 to 
remove unbound protein until the flow-through had minimal absorption at 280nm. 
The column was then washed through with 4 or 5 column volumes of 0.1 M NaCL to 
remove bound impurities before Fcc3 was eluted with 0.2 M NaCl in a series of 20 ml 
fractions. Fractions were retained depending on the ratio of absorbance at 408 nm 
(haem) to that at 270nm (total protein). For pure protein, Abs 408/Abs270 is 
approximately 4 [Kate Pankhurst, 2002], but at this stage, fractions with a ratio >1 
were kept. Retained fractions were dialysed (x2) in 4 litres 10mM TRIS pH 8.4. 
2.2.4. Anion exchange, Hydroxyapatite 
A 60ml Hydroxyapatite column (Bio-Rad) was equilibrated with about 5 column 
volumes 10mM TRIS before loading protein. The column was washed through with 
10mM TRIS to remove unbound protein before eluting Fcc3 with 0.1 M K2HPO 4 
(fisher scientific). The purity was checked by U.V. spectroscopy as before and 
fractions with Abs408/Abs270 > 2.5) were retained, then dialysed against 10mM TRIS 
pH 8.4. 
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2.2.5. FPLC - Fast Protein Liquid Chromatography 
FPLC (AKTA, Amersham Pharmacia Biotech) is an automated step that uses a 60 ml 
HiLoad 26/10 strong anion exchange Q sepharose column. The column was 
equilibrated with buffer A prior to loading of protein then washed through with 
several column volumes of buffer A. Fcc3 was eluted using a linear salt gradient (0 - 
0.5M) achieved by addition of 0— 100% buffer B. 
2.3. Determination of protein concentration and FAD content 
2.3.1. Determination of protein concentration 
The concentration of purified Fcc 3 was determined by measurement of its absorbance 
at 41 9nm using a Shimadzu UV-21 01 PC spectrophotometer after its reduction by 
sodium dithionite (Fisher scientific) (s = 752800 M'.cm' [Pealing eta!, 1995]). 
Protein concentration is calculated using the Beer-Lambert equation; 
A=c.c.l 
where A = Absorbance, c = molar absorbance(M'.cm 1 ) and 1 = pathlength (cm). 
2.3.2. FAD determination 
FAD is bound non-covalently to Fcc3. Recombinant Fcc 3 is not expressed with a full 
complement of FAD and also, some may be lost during purification. To determine 
the percentage of Fcc3 that retained bound FAD, 150 tl of 50% Trichioroacetic acid 
was added to TRIS buffer containing the equivalent of 50p.1 of 801.iM protein, and 
made up to a total volume of 1250 jil with buffer. The precipitated haem and protein 
was pelleted by centrifugation in a microcentrifuge (eppendorf) for 2 minutes, leaving 
FAD in the supernatant. The supernatant was removed and adjusted to pH 7 by 
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addition of Na2CO3 (Fisher Scientific) before measurement of absorbance at 450nm (c 
= 11, 100). FAD concentration is compared to Fcc3 concentration and FAD content is 
taken as a percentage (one Fcc3 molecule binds one molecule of FAD). All kinetic 
measurements are adjusted to assume FAD content of 100%. 
2.4 Gel electrophoresis 
The eluate obtained from each stage of purification was analysed by SDS-
polyacrylamide gel electrophoresis followed by Coomassie Blue staining to determine 
the presence and purity of Fcc3 
Figure 2.1 Coomassie stained gel showing pur ification of Fcc3 
- 
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Lane I = cell lysate, lane 2 = after 40% Ammonium sulphate precipitation, lane 3 = after anion 
exchange - DE-52, lane 4 = after anion exchange on Hydroxyapatite, lane 5 = after fast protein liquid 
chromatography - Q Sepharose, lane 6 = pure wild-type Fcc 3, lane 7 = protein markers. 
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4X NuPAGE LDS sample buffer (20p1) was added to protein samples (the amount 
added depends on the concentration of Fcc3 present determined by UV-Vis 
spectroscopy) and made up to 50 p.! volume with H20. Samples were then boiled for 
two minutes before being loaded on to a prepoured WAGE 4-12% Bis Tris gel 
(Invitrogen) which was immersed in NuPAGE Mes running buffer. The voltage was 
held at 150 V for approx 45 minutes (or until the gel front reached the bottom). The 
gel was then stained with a solution containing 1% Commassie Blue, 40% methanol 
and 10% glacial acetic acid. The gel was then rinsed with destaining solution (40% 
methanol, 10% glacial acetic acid) to reveal protein bands. A mixture of marker 
proteins of known molecular weight were also added (figure 2. 1, lane 7), in order to 
check that purified protein was the correct mass. It can be seen from the gel in figure 
2.1 (lane 6) that pure protein is obtained using the purification method described in 
this chapter. 
2.5. Steady state Kinetics 
Buffers: 
pH 6.0, 6.5, 50mM MES (Sigma) 




--1 mM Methyl viologen (Sigma) 
	
l mM Methyl viologen 
pH 9.0-10.0, 50mM CHES (Sigma) 
0.45M NaC1 
-1 mM Methyl viologen 
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The activity of Fcc3 for the reduction of 2-methylfumarate (Fluka) was assayed by 
monitoring the oxidation of an artificial electron donor, methyl viologen (shown 
below). The reduced form of methyl viologen readily donates electrons to Fcc3 in 
vitro because it has a much lower reduction potential (E = -430 mV). These electrons 
are then transferred to substrate by enzymatic reduction. The assay is limited to pH 6 
and above as dithionite - which is used to reduce methyl viologen - breaks down 
under more acidic conditions [Doherty, 1999]). 
N - 
	
Me 	 Me 
All assays were performed under anaerobic conditions in Belle Technology glovebox 
(02 < 5 ppm) at 25°C. A few milligrams of MV was included in buffer prior to 
degassing (oxygen in solution replaced with nitrogen). The reduced form of methyl 
viologen absorbs strongly at 600 nm with a molar absorbance (6) of 13000 M cm* 
The oxidized form has 6600 = 0, so as it loses electrons, there is an observable loss in 
absorbance (colour changes from blue to colourless upon oxidation). An aliquot of 
sodium dithionite was added to 3ml of buffer in a cuvette to give an Abs600 of '1 .0 
(approximate concentration of MV red = 80 p.M). Protein was incubated in the buffer 
and the assay intitated by addition of substrate. The decrease in Abs600 was monitored 
over time using a Shimadzu UV-PC 1501 spectrophotometer. The rate of decrease 
reflects the rate of reduction by Fcc3 according to the formula below. 
kobs  = 	AAbs 
X 	X [E] 
1 
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2.6. Bulk reduction 
Millimolar concentrations of methylsuccinate product were required for subsequent 
analysis. This was achieved via a bulk electrochemical reduction using a 3 electrode 
cell shown in fig 2.2. Current was passed through solution (using platinum electrodes 
plus an AgIAgCl reference 
















electrode) in order to keep the reaction going until all the substrate was used up (the 
potential was held at —0.6 V). Although the reduction of 2-methylfumarate proceeds 
faster at pH 9.0 (see results), the pH was kept neutral. This is because Fcc3 is less 
stable at pH 9.0 and would lose activity before the reduction was complete. Protein 
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was separated from product by centrifugation through a 10 kDa membrane 
(Centriprep, Millipore) 
2.7. Circular Dichroism 
Circular Dichroism spectroscopy (Jasco J-8 10 spectropolarimeter) was used to 
determine the configuration of the chiral centre in methylsuccinate. R and S-
methylsuccinate molecules rotate polarized light in opposite directions and so absorb 
light differently. CD spectra of the product (generated by electrochemical reduction) 
were compared with spectra of standard R-methylsuccinate and S-methylsuccinate 
(Sigma). The concentration of methylsuccinate was - 500 tM in quartz cell, 
pathlength - 1cm. 
2.8. Crystallisation and refinement 
All crystal structures of wild-type and mutant forms of flavocytochrome c3 were 
obtained by Dr Christopher Mowat. Crystallisation was carried out by hanging drop 
vapour diffusion at 4 °C in Linbro plates. Crystals were obtained with well solutions 
comprising 100 mM TrisHCl buffer (pH 7.8-8.5)(measured at 25 °C), 80 mM NaCl, 
16-19 % PEG 8000. In the case of the wild-type enzyme 1 mM 2-methylfumarate 
was present in the well solution, for the T377A mutant enzyme 10 mM fumarate was 
used, and for the H365G enzyme 10 mM trans-2-methyl-2-pentenoate was present. 
Hanging drops (4 j.il volume) were prepared by adding 2 jil of 6 mg/ml protein (in 10 
mM TrisHCl pH 8.5) to 2 tl of well solution. After approximately seven days 
needles of up to 1 mm x 0.2 mm x 0.2 mm and plates of up to 0.5 mm x 0.5 mm x 0.2 
mm were formed. Crystals were immersed in a solution of 100 mM sodium acetate 
buffer (pH 6.5), 20 % PEG 8000, 1 mM 2-methylfumarate! 10 mM fumarate, 10 mm 
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trans-2-methyl-2-pentenoate as appropriate, and 80 mM NaCl, containing 23 % 
glycerol as a cryoprotectant, prior to being mounted in nylon loops and flash cooled in 
liquid nitrogen. For the wild-type enzyme a data set was collected to 1.5 A at station 
14.1 (?. = 0.975 A) at SRS Daresbury using an ADSC Quantum 4 CCD detector. 
Crystals belonged to space group P 2 1 with cell dimensions a = 45.449 A, b = 91.687 
A. c = 78.287 A, and/3 = 91.13 • For the T377A mutant enzyme data to a resolution 
of 2.0 A were also collected at SRS Daresbury (station 14.1; ? = 0.975 A) using the 
same detector. These crystals were found to belong to space group P 2 1 with cell 
dimensions a = 45.33 1 A, b = 91.415 A, c = 78.171 A, and fl = 91 . 120 .  In the case of 
the H365G mutant enzyme a data set to a resolution of 1.9 A was collected at ERSF 
Grenoble (beamline BMI4; ? = 0.9785 A) using a Mar Research Mar225 detector. 
The crystals belonged to space group P 2 1 2 1 2 1 with cell dimensions a = 57.642 A, b 
= 83.322 A, and c = 139.703 A. 
In all cases data processing was carried out using the HKL package [Otwinowski and 
Minor, 1997]. The wild-type flavocytochrome c3 structure (PDB ID: 1QJD), stripped 
of water, was used as the initial model. Electron density fitting was carried out using 
the program Turbofrodo [Roussel and Cambillau, 1991] and structure refinement was 
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3.0 Introduction 
Crystal structures were obtained for WT (wild-type) Fcc3 and two engineered forms 
of the enzyme (T377A, H365G). Data refinement statistics for all three structures are 
included in table 3.1. There were already several crystal structures of WT and mutant 
forms of Fcc 3 available but all were bound to fumarate. The aim was to find out if 
there were any differences in binding interactions with the enzyme active site when 2-
methylfumarate was the substrate. As will be discussed in chapter 5, alterations to 
the active site were made by substituting amino acid residues that form hydrogen-
bonds with the substrate. A crystal structure was obtained for mutant Fcc 3 where 
threonine 377, which forms two hydrogen-bonds with fumarate at the WT active site, 
was replaced with alanine (T377A). Another mutant (H365G) contained a glycine 
residue at position 365, which is normally occupied by a histidine that forms a single 
hydrogen bond with the substrate. Crystals obtained for WT and T3 77A were in the 
"closed" form, with substrate bound. The H365G crystals were formed from Fcc 3 
without substrate bound, in the "open" conformation. Crystallographic results for 
each structure are discussed in the following pages. 
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Table 3.1 - Crystallographic data for WT, T377A and H365G Fcc 3 
resolution (A) 24.0-1.5 50.0-2.0 50.0- 1.9 
total no. of reflections 678137 249461 699812 





(1.97- 1.90 A) 
completeness (%) 97.2 (94.0) 98.2 (83.6) 993 (96.2) 
I/[c(I)] 21.0 (3.1) 11.8 (5.1) 15.1 (2.2) 
Rmerge (%)a 4.8 9.0 6.8 
Rm erge in outer shell (%) 37.3 16.7 49.5 
R(%) t' 15.08 16.13 19.45 
Rfree (%)b 18.35 19.78 23.98 
rmsd from ideal values 
bond lengths (A) 0.014 0.016 0.019 
bond angles (deg) 1.5 1.4 2.1 
Ramachandran analysis 
most favoured (%) 88.1 89.1 87.3 
additionally allowed (%) 11.7 10.9 12.4 
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3.1 Crystal Structure of Fumarate Reductase with 2-Methylfumarate Bound 
A data set to 1.5 A resolution was used to refine the structure of wild-type 
flavocytochrome c3 with 2-methylfumarate bound to a final R-factor of 15.08 % (R 
= 18.35 %), and the data collection and refinement statistics are summarised in table 
3.1. The final model consists of one protein molecule comprising residues 1-568, four 
hemes, one FAD, one sodium ion, one 2-methylfumarate molecule, and 1249 water 
molecules. The atomic coordinates have been deposited in the Protein Data Bank, 
accession code: 1 YOP. 
The quality of the final electron density map around the FAD and 2-methylfumarate is 
shown in figure 2(a). As found for other FR structures, residues 569-57 1 at the C-
terminus of the enzyme could not be located in the electron density maps. The rmsd 
fit of all backbone atoms between this model and the earlier wild-type enzyme 
structure (PDB ID: IQJD) [Taylor et al, 1999] is 0.2 A, indicating no major 
differences between the two protein structures. 2-Methylfumarate is found at the 
active site of the enzyme in the same twisted conformation observed for the malate-
like molecule (henceforth referred to as malate for the sake of simplicity) in the 
original crystal structure (PDB ID: 1 QJD) [Taylor et al, 1999] and for fumarate in 
structures of mutant forms of the enzyme (e.g. PDB ID: 1JRX) [Mowat et al, 2001]. 
An overlay of 2-methylfumarate (in purple) and the malate from the structure of 
Taylor et al is shown in figure 2(b), indicating the complete superposition of the two 
with the exception of the C2-substituent on each. Accordingly, the bound 
2-methylfumarate maintains the same interactions with the protein as displayed by 
malate. These include an electrostatic interaction between the C 1 -carboxylate group 
and the positively-charged sidechains of Arg544 and His 504 which serve to polarise 
and activate the double bond for hydride attack by FAD. The C4-carboxylate end of 
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Figure 3.1 (a) Stereoview of the active site of the wild-type enzyme with 2-Me-fumarate bound. The 
electron density map was calculated using Fourier coefficients 2F0 - F, where F. and F are the 
observed and calculated structure factors, respectively, the latter based on the final model. The contour 
level is lo-, where or is the rms electron density. (b) Siereoview of the overlay of 2-Me-fumarate 
(purple) and the ma/ate-like substrate found in the initial wild-type structure (PDB ID IQID). (c) 
Stereoview of the active site of the 2-Me-fumarate bound wild-type enzyme. All of the important 
substrate interactions with fumarate are maintained in the case of2-Methylfumarate. 
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2-methylfumarate is hydrogen bonded to several residues including His635 and 
Thr377. The interactions of 2-methylfumarate at the active site of FR are shown in 
figure 2(c). The mechanism of 2-methy1fumarate reduction is assumed to be the same 
as that shown for fumarate in figure 1, and is proposed to involve proton delivery via 
a pathway comprised of Arg381, G1u378, and Arg402. In the 2-methylfumarate-
bound protein all proton transfer distances are identical to those observed in the 
malate-bound structure, as is the hydride transfer distance from FAD to substrate. 
These results are discussed in relation to the kinetics of 2-methylfumarate reduction 
by WT Fcc3 and the stereochemistry of 2-methylsuccinate in chapter 4. 
3.2 Crystal Structure of the T377A Mutant Enzyme 
A data set to 2.0 A resolution was used to refine the structure of Fcc 3 T377A to a final 
R-factor of 16.13 % (R j'ree = 19.78 %), and the data collection and refinement statistics 
are summarised in table 3.1. The final model consists of one protein molecule 
comprising residues 1-568, four hemes, one FAD, one sodium ion, one fumarate 
molecule, and 376 water molecules. The electron density around the active site is 
shown in figure 3.2 (a). The substitution of threonine 377 by alanine is shown to 
remove two hydrogen-bonding interactions between the residue and the bound 
fumarate molecule that is observed in the structure of the wild-type enzyme (figure 
3.2 (b)). This results in the fumarate being oriented slightly differently than is 
observed for the bound malate molecule in the wild-type enzyme. In this mode of 
binding the fumarate is less twisted than observed in the wild-type enzyme (and 
therefore less activated toward hydride attack during catalysis), while other important 
interactions with the protein are maintained. These include electrostatic interactions 
with Arg544 and His504, a hydrogen-bonding interaction with His365, and 
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Figure 3.2 (a) Stereoview of the active site of the T377A mutant enzyme. The electron density map was 
calculated using Fourier coefficients 2F0 - F. where F,, and F, are the observed and calculated 
structure factors, respectively, the latter based on the final model. The contour level is I o where er is 
the rms electron density. (b) Stereoview of the overlay of the active sites of wild-type (green) and 
T3 77A enzymes showing the different  orientations of the bound substrate. The hydrogen bond between 
Thr3 77 and the substrate carboxylate is shown. 
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maintenance of the hydride- and proton-transfer distances observed in the wild-type 
enzyme. Further discussion of T377A structure in context with kinetics of fumarate 
and 2-methylfumarate reduction is included in Chapter 5. 
3.3 Crystallisation of H365G 
Enzyme crystallisation conditions were the same as described in chapter 2 (materials 
and methods) except that prior to crystallisation, Fcc 3 (H365G) was put through a G25 
filtration column. The reason for this was to remove fumarate, which in all crystal 
structures (apart from WT with 2-methylfumarate bound) is always bound to the 
active site. In addition, Fcc 3 (H365G) was incubated with 10mM trans-2-methyl-2-
pentenoate. in order to ascertain if it would bind to the active site (it had not yet been 
confirmed by enzyme assays that this would not occur). It was thought that fumarate 
may be bound to the active site of Fcc 3 upon its expression and remains bound 
throughout purification. It was proposed that the presence of fumarate competitively 
prevents binding of other substrates, so it was hoped that its removal would promote 
binding of other substrates. Even if this was not the case, it was hoped that removal 
of excess fumarate would result in crystals of Fcc 3 that did not have substrate bound. 
Up to this point crystal structures of "substrate free" Fcc 3 had not yet been obtained. 
3.3.1 Crystal Structure of the H365G 
A data set to 1.9 A resolution was used to refine the structure to a final R-factor of 
19.45 % (Rçrec = 23.98 %). The final model consists of one protein molecule 
comprising residues 1-568, four hemes, one FAD, one sodium ion and 325 water 
molecules. The electron density around the FAD is shown in figure 3.3 (a). 
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Figure 3.3 Crystal structure of H365G 
Figure 3.3 (a) The electron density around the FAD in the structure of the H365G mutant enzyme. The 
electron density map was calculated using Fourier coefficients 2F,, - F, where F. and F are the 
observed and calculated structure factors, respectively, the latter based on the final model. The contour 
level is / o where a- is the rms electron density. (b) Overlay of the H365G mutant enzyme (greenl 
purple) with that of the JFcc3 (PDB ID 1Q08). 
In this case the protein is observed in the open conformation with no substrate bound 
at the active site (the structures obtained for WI and T377A are all in the closed 
conformation with substrate bound). This is analogous to the structure of the 
substrate-free iron-induced iso-fcc 3 (IFcc3) fumarate reductase from Shewanella 
frigidimarina (Bamford et al. 1999: PDB ID 1Q08) which is super-imposable with 












domain 9- ~ - MI J rd 
His 365 
Biocatalysis offurnarate derivatives byflavocytochrome c 3 





a) Global protein structures of WT Fcc3 in the closed conformation (red) overlaid on IFcc3 in the open 
conformation [Bamford et al, 1999]. The clamp domain has moved 14° relative to the flavin domain in 
the open conformation. The arrow indicates the direction of movement. b) Close-up of active site for 
the closed (red) and open (yellow) conformations. c) H365G global structure (blue) overlaid on IFcc 3 
(yellow). d) Close-up of active site. Positioning of residues is similar in H365G (blue) to !Fcc 3 
although substitution with glycine (circled) increases the space available. 
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3.3.2 Comparison of open and closed Fcc3 
As mentioned in the introduction, the clamp domain is capable of some movement. 
This is illustrated in figure 3.4 a) by the crystal structures of "closed" WT Fcc3 (in 
red) superimposed on to "open" IFcc 3 (iron-induced Fcc3, an isozyme of Fcc 3 shown 
in yellow) [Bamford et al, 1999]. It would appear that the clamp domain is able to 
move 14 degrees relative to the flavin domain. It can be seen from figure 3.4 b) that 
the relative positioning of some of the residues to FAD is different and that there is 
more space available for product release/entry of substrate in the open conformation. 
Figures 3.4 c) and d) show H365G (in blue) overlaid on to 1Fcc (yellow) and it can 
be seen that they are in the same open conformation and that the active site is not 
much altered with respect to positioning of surrounding active site residues. 
However, the substitution of histidine 365 with glycine appears to have increased the 
size of the active site cavity. Without a crystal structure of H365G with substrate 




Reduction of2-methylfumarate by WT Fcc3 
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4.0 Introduction 
As mentioned briefly in the introduction (chapter 1.5), Fcc 3 is able to bind 2-
methylfumarate which acts as a potent inhibitor of fumarate reduction. It has a K 1 of 1 
iM and it also inhibits the reverse reaction - oxidation of succinate to fumarate - with 
a K1 of 32.3 tM [Moysey, 2001]. Previous studies had not revealed whether 2-
methylfumarate was actually reduced to 2-methylsuccinate by Fcc3 so it seemed 
logical to investigate this. Also, because the product of 2-methylsuccinate reduction 
is chiral, its stereochemistry could be used to determine hydride and proton transfer 
trajectories, which although they have been predicted, have not yet been confirmed 
experimentally. 
The activity of Fcc3 was assayed by monitoring the oxidation of an artificial electron 
donor, methyl viologen (see materials and methods). In order to carry out reduction 
of the substrate, the active site must be constantly supplied with electrons. The 
reduction of 2-methylfumarate by WT (wild-type) Fcc 3 proceeds at different rates 
depending upon environmental pH and concentration of substrate present. Fcc 3 
exhibits Michaelis-Menten kinetics and measurement of reduction rates at increasing 
concentrations of substrate allows the determination of k cat and Km values. Figure 4.1 
shows plots of observed rate constants (k 0b ) versus 2-methyiflimarate concentration at 
pH 7.2 (a) and pH 9.0 (b). 
-65- 
Biocatalysis offumarate derivatives byflavocytochrome c 3 
Figure 4.1 Reduction of 2-methylfumarate by WT Fcc3 at pH 7.2 
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a) Plot of 2-methylfumarate reduction by wild-type Fcc 3 at pH 7.2 b) at pH 9.0. Observed rate 
constants versus substrate concentration were fitted to the Michaelis-Menten equation by least squares 
regression using Microcal Origin. 
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4.1 Kinetic parameters for 2-methylfumarate reduction by WT Fcc 3 
Rate constants for fumarate reduction established from previous studies [Turner et a!, 
19991 are listed alongside those obtained for 2-methylfumarate in table 4.1. The 
activity of Fcc 3 is approximately 50-fold lower with 2-methylfumarate than that 
observed for fumarate with a k cat (maximum rate) at pH 7.2 of 9.0 s_ I ± 0.4. The Km is 
only slightly increased relative to furnarate at 32.0 .tM ± 8.5 which is consistent with 
data obtained from prior experiments that demonstrated that it is a potent inhibitor of 
fumarate reduction when both are present [Moysey, 2001]. 
Table 4.1— Kinetic parameters for fumarate and 2-methylfumarate reduction by wild-
type Fcc3 
Fumarate 
pH kcat(S ' ) Km (.tM) kca tfKm (M's') 
7.2 509±15 25±2 2x107 
9.0 210±13 7±2 3x107 
2-methylfumarate 
pH kcat(S5 Km (p.M) kcat/Km (M's') 
7.2 9±0.4 32±8.5 3x10' 
9.0 12±0.6 15± 4.5 8x105 
Although the Michaelis constant for 2-methylfumarate reduction indicates that it 
binds to the active site as readily as fumarate does, there is a drop in catalytic 
efficiency (kcatlKm) by a factor of 100. When fumarate is the substrate, the rate of 
reduction at pH 9.0 decreases to less than 50 % of the activity observed at pH 7.2 
[Doherty, 1999]. However, when 2-methylfumarate is the substrate, reduction 
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actually increases at pH 9.0 by about 30% compared to rates observed at pH 7.2, with 
a kcat of 12 s ± 0.6. As with fumarate, the K m is lowered at pH 9 although to a lesser 
degree, but the catalytic efficiency (k <at/Km) actually increases. The pH profiles for 2-
methylfumarate and fumarate reduction are shown in figure 4.2. The data for 2-
methylfumarate fit a bell-shaped curve with two pKa values (7.09 ± 0.22, and 9.92 ± 
0.21) and activity is greatest at approximately pH 9.0. Fumarate reduction has an 
optimum pH of 6.0 (rate = 658 5 ' ±34) [Turner eta!, 1999] and a single pKa of 7.5 ± 
0.1 [Pankhurst, 2003] but at pH 6.0, the rate of 2-methylfumarate reduction is lowest, 
at 7.0 s_ I ± 0.6. 
Figure 4.2 Comparison offumarate and 2-methylfumarate reduction rates at 
















6 	 7 	 8 	 9 	 10 
p1-I 
Graph showing pH curves for furnarate (blue) and 2-methylfumarare (red). Data fitted 
as before using Microcal Origin 
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4.2 Structure of bound 2-methyifumarate 
The crystal structure of Fcc 3 complexed with 2-methylfumarate was recently solved 
by our laboratory to 1.5 A (fig. 4.3 a). As in the structure previously published by 
Taylor et a! [1999] with malate bound (fig 4.3 b), the enzyme is in the closed 
conformation and the substrate is bound to the active site by formation of multiple 
hydrogen bonds with the surrounding residues. The carbon atoms of the substrate in 
figures 4.3 a) and 4.3 b) are numbered I - 4 so that their orientation to the flavin 
alloxazine ring can be compared. It can be seen that in both structures, the Cl 
carboxylate of the substrate is twisted out of plane. As previously mentioned in the 
introduction, this twisted conformation results from hydrogen-bonding and steric 
constraints imposed by nearby residues when the clamp is in the "closed" position. It 
was thought that the decrease in rate when 2-methylflimarate is the substrate, may be 
partly due to slight differences in the positioning of substrate relative to active site 
residues, due to the presence of the extra methyl group. The crystal structure shows 
that this is unlikely to be the case because not only does 2-methylfumarate retain the 
same hydrogen-bonding contacts as fumarate, distances for hydride and proton 
transfer also remain the same. This is consistent with the similarity in K m values 
obtained for fumarate and 2-methylfumarate indicating that both bind as readily to the 
active site. The mechanism proposed for the two-electron reduction of substrate by 
hydride transfer is driven by polarisation of the C2 - C3 double bond, aided by 
twisting of the Cl carboxylate and the positively charged environment around the C4 
carboxylate. The crystal structure demonstrates that these two factors are still present 
when 2-methylflimarate is bound. However, the methyl substituent inductively 
donates electrons which would interfere with bond polarisation and/or destabilise the 
localised build-up of negative charge around C3 that occurs upon formation of the 
MOOR 
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Figure 4.3 Crystal structures offcc3 with substrate bound at the active site 
a) with 2-methylfumarate 
b)with malate-like molecule 
T377 
ii 
Crystal structures of the active site of Fcc 3 (wild-type) with 2-methylfumarate (a) and a hydrated 
intermediate derivedfromfumarate (b). The red dashes represent the path of hydride transfer, the 
blue dashes show theproton transfer pathway and the yellow dashes indicate hydrogen bonding 
contacts 
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transition state. In order to overcome this, a larger amount of free energy would be 
required for formation of product and it is thought that this may be the reason for the 
observed decrease in kcal . 
4.3 Stereochemistry of 2-methylsuccinate 
The reduction of 2-methylfumarate results in the formation of 2-methylsuccinate, 
which has a chiral (asymmetrical) centre, and could be present as either the R or S 
enantiomer shown below. (Enantiomers are stereoisomers which are mirror images of 
each other and are non-superimposable, differing only in the arrangement of atoms 
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As mentioned in the introduction, the crystal structure of fcc 3 obtained previously by 
Taylor et a! [1 999] contained a malate-like molecule (instead of fumarate) bound at 
the active site with a chiral centre at the C2 position displaying R-stereochemistry 
(see fig 4.3 b and 4.4 b). When compared with the crystal structure showing 2-
methylfumarate (fig4.3a and 4.4 a), it can be seen that the mode of binding to the 
active site is actually different. The methyl substituent is located at the C3 position 
(site of proton transfer from Arg 402) and based on the mechanism proposed, hydride 
transfer followed by protonation would result in S-methylsuccinate being produced 
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Figure 4.4 Mode of2-methylfumarate binding at Fcc3 active site 
C) 	 0 	0- 
N5(FAD) 
 30 

























a) Mode of 2-methylfumarate binding relative to the alloxazine ring of FAD from the crystal structure. 
The angle between the substrate and the alloxazine ring of the flavin is shown, as is the distance for 
hydride transfer from N5 of the flavin to substrate, on the carbon that does not contain the methyl 
group b) The ma/ate-like molecule (from crystal structure) binds in exactly the same way with the same 
angle and distance however the hydride is transferred to the carbon which has a substituent attatched 
to it c) mechanism of S-methysuccinate formation, d) mechanism of R-methylsuccinate formation if the 
substrate bound in a manner analogous to that in figure b) 
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(figure 4.4 c). If it bound in an analogous manner to the malate-like molecule (with 
the substituent located at the C2 position subject to nucleophilic attack by N5 of the 
Flavin), then R-methylsuccinate would be produced (figure 4.4 d). In order to 
determine the stereochemistry of the product, bulk reduction of 2-methylfumarate 
using coulometry was performed to make enough product for subsequent analysis by 
circular dichroism spectroscopy. 
4.4 Bulk electrocatalytic reduction of 2-rn ethylfumarate 
Various electrochemical techniques have been employed in the study of Fcc 3 and it 
has been shown that catalytic reduction can be effectively driven electrochemically. 
A 3-electrode cell was set up with platinum working and counter electrodes and a 
Ag/AgCI reference electrode. Methyl viologen was added to the buffer (final 
concentration was 50 p.M) and the concentration of fcc 3 present was approximately 
ltM. The potential was held at -600mV until 5mM 2-methylfumarate was 
electrocatalytically reduced. 5mM substrate was chosen as previous tests of standard 
R and S-methylsuccinate using the CD spectropolarimeter had produced the most 
reliable traces at this concentration. The end point of the reaction could be detected by 
a flattening out of the trace as current ceases to flow (no more substrate left to act as 
an electron acceptor). 
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Time (s) 
Ttrace showing electrochemically driven reduction of 2-methylfumarate by Fcc 3. The reaction stops 
when all of the substrate has been consumed and transfer of charge ceases 
4.5 Circular Dichroism spectroscopy of 2-methylsuccinate 
The product was compared with samples of enatomerically pure R and S-
methylsuccinate obtained commercially (Sigma). It can be seen from fig. 4.6 that the 
trace for product is identical to that obtained for S-methylsuccinate suggesting that 
reduction of 2-methylfumarate by WT Fcc3 always produces S-methylsuccinate. 
Therefore, the circular dichroism spectrum of product conclusively showed that 
reduction is stereospecific with the S-enantiomer being produced. 
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R (+) -Methyl Succinate 
S (-) -Methyl Succinate 
Product 
210 	220 	230 	240 	250 
Wavelength (nm) 
CD traces obtained for R-methylsuccinaie (red), S-methylsuccinaze (blue) and product of bulk reduction 
of 2-rn ethylfumarate by WT Fcc 3. The ellipticity (which is proportional to the difference in absorbance) is 
on they axis and the wavelengths of light utilised by the polarimeter are on the x axis. A racemic mixture 
of both R and S methylsuccinate (not shown) was also tested and is seen as aflat line at 0 mdeg. 
4.6 Conclusions 
The CD results along with the crystal structure of WT Fcc3 with 2-methylfumarate 
bound at the active site, appear to confirm predicted hydride and proton transfer 
trajectories and the two-step mechanism for fumarate reduction originally proposed 
when the crystal structure of Fcc3 was obtained in 1999 [Taylor et a!, 1999]. 
Theoretical studies recently carried out using density functional theory also support 
this [Lucas and Ramos, 2006]. Bulk reduction in vitro (see materials and methods) 
seems to be an effective and relatively simple way of obtaining product from Fcc 3 at 
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concentrations useful for further study. These results raised the possibility that Fcc3 
would be able to catalyse the reduction of other derivatives of fumarate (with different 
groups at C3) that result in chiral products. Chiral synthesis using biocatalysis is 
currently being researched by many labs, and advances in genomic analysis mean 
genomes can now be "mined" for potential biocatalysts. Possible applications include 
drug development [Patel, 2001], industrial synthesis of bulk chemicals [Shoemaker et 
al, 2003] and organic synthesis [Koeller and Wong, 2001]. In light of this, it is of 
interest to determine whether Fcc 3 could be used to produce other stereospecific chiral 
compounds. 
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5.0 Introduction 
To date there have been two enzymes discovered that are capable of reducing the 
mono-acid methacrylate (table 5.2). A 50 kDa periplasmic flavoprotein purified from 
Geobacter sulfurreducens AM-] [Galouchko et al, 1996], and a 52 kDa periplasmic 
flavoprotein which is the product of the fccA gene from Wolinella succinogenes 
[Gross et a!, 2001]. The G. sulfurreducens flavoprotein is dependent on a 30 kDa 
cytochrome c for activity and it is able to catalyse the reduction of Methacrylate, 
acrylate, crotonate and pentenoate [Mikoulinskaia et a!, 1999]. The gene responsible 
for expression of this protein has not yet been identified so only the N-terminal 
sequence has been elucidated. It was found to have 80% similarity to the 52kDa 
protein from W. succinogenes FccA, which shares 31% identity to the C-terminal 
section of Fcc3 (figure 5.1). The active site of Fcc3 contains what has been dubbed the 
"HPT triad" (highlighted in cyan), which includes histidine 365 and is a conserved 
feature of all fumarate reductases, but is absent in FccA [Gross, 2001]. Instead there 
is a glycine at this position and the threonine residue is replaced with tryptophan. 
Also, instead of T377 (highlighted in cyan) there is a valine. The other active site 
residues (R402, H504, H505 and R544 highlighted in yellow) are conserved. Activity 
tests had shown that WT Fcc3 was not able to bind or reduce any of the potential 
substrates shown in table 5.2 other than fumarate and 2-methylfumarate. FccA is 
able to reduce acrylate and methacrylate, so it was thought that substitution of H365 
and T377 as well as H504 (another residue that forms hydrogen-bonds with substrate) 
with other amino acids may enable Fcc 3 to catalyse reduction of these mono-acids. 
R402 was not substituted as it has been previously shown to be critical for enzymatic 
activity (see enzymatic mechanism in section 1.4.4). 
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Figure 5.1 Protein Sequence alignment of Fcc3 from S. frigidimarina and FccA 
from W. succinogenes 
Fcc3 	 GDGLDVAENAGGALKDMQY I QLSVF'------ GGvM'JIEAVFGNGAILVNREGIRFV 396 
FccA AGVLLAFGIGAVPVQVS'. Q 	CY DEG GGSMFNINASFPYGISVDPKTGKRYr.1  338 
I. 	.. 	.'- .. 	 . 	. 
Fcc3 	 NEITTRDKASAAILAQTGKSAYFDDSVPKSLS ----- KIDKYIGLGVAPTADSLVKLG 451 
FccA NELADRKIRADMMFAVIGKDENYPINLCDSQAIERLLPDHYEKALKAGILKKFNTLEELA 398 
* 	.. 	... 
Fcc3 	 KMEGIDGKALTETVPRYNSLVSSGKDTDFEPPN --- LPPALNEGNYYAIEVTPGVHKTMG 508 
FCCA QQYKMPVEAFKYTVTDYNSY1KAGYDPEFGKPTNMVDG1TLSIAPFYANRGTPKL}{HTMG 458 
......... *** 	* 	.......... 	. 	. v•fr 
Fcc3 	 GJMIDTKAEVMNA-KQVIPGLYGAGEVTGGVHGANRLGGNAISDIITFGRLAGEEAAKY 567 
FccA GLQINTQAQVIHSKTHQPIPGLYAAGEVTGGVHGASRLGSVAITDCLTFGMIAGENI--- 515 
............. * 	.* 	k**,* 	P*.**it1* 	* ............ 
Alignment comparing Fcc 3 from Shewanellafrigidimarina and FccA from Wolinella succinogenes 
generated using Clustal W. The HPT motif is highlighted in cyan and is conserved in all fumarate 
reductases. The residues located at the equivalent position at the active site are highlighted in green. 
R402, H504, H505 and R544 are conserved between the two proteins and are highlighted in yellow. 
R544 was also left untouched as it is important for the polarisation of the C2-C3 
double bond, an important aspect of the catalytic mechanism. Therefore, the mutants 
shown in table 5.1 were constructed by site directed mutagenesis. Table 5.2 lists 
potential substrates for engineered forms of Fcc3. These particular chemicals were 
chosen because their size and shape could be expected to be accommodated by the 
active site cavity and are compounds that are found abundantly in environments that 
Shewanella species inhabit (mono-acids and mono/di-esters) and because some of 
them would result in chiral compounds if reduced (e.g. tiglic acid). The resulting 
stereochemistry of these products would give valuable information about hydride and 
proton transfer trajectories as well as other aspects of the enzymatic reaction 
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mechanism. The various mutant forms of Fcc3 will be discussed in this chapter with 
regard to their properties and their ability to reduce any of the compounds listed in 
table 5.2. 
Table 5.1 - Fcc3 mutants constructedfor activity studies 
H365A 	 H365L 	H365G 
H504A 	 H3651 
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methyl-3-aminocrotonate Cinnamic acid 
Y 	0 0 
Dimethylfumarate Monoethylfumarate 
The table shows examples of some unsaturated organic acids tested as potential substrates for Fcc3 . 
Highlighted in pink are fumarate and 2-methylfumarate which are turned over by WT and most of the 
mutants. JUPAC names for all of the above chemicals are listed in appendix 
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a) Active site of Fcc 3 showing hydrogen bonding interactions (blue dashes) between the ma/ale-like 
substrate and active site residues. Circled are residues which were substituted with alanine to 
generate the mutants listed in table 4.3 b) Structures of amino-acids histidine, threonine and alanine. 
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5.1 Substitution of active site residues with alanine 
It was thought that replacing one or more of the hydrogen-bonding residues with 
alanine (figure 5.2) would possibly increase the size of the active site cavity and thus 
allow binding of substrates with bulkier functional groups. Previous work carried out 
by our laboratory had demonstrated that substitution of histidine 365, histidine 504 
and threonine 377 with alanine (a smaller non-polar residue) did not entirely abolish 
activity for the reduction of fumarate [Doherty 1999. Pankhurst, 2003]. All amino-
acid substitutions were done using site directed mutagenesis (see materials and 
methods). Table 5.3 contains rates of fumarate reduction by mutant forms of fcc 3 at 
pH 7.2. 
Table 5.3 kinetic parameters for reduction offumarate by mutant forms offcc3  at 
pH 7.2 
'(cat (s') Km (IM) kcat/Km (Ms') 
WT 509± 15 25 ±2 2.0x 10 
H365A 52±2 259± 20 2.0x 
H504A 65 ± 3 256 ± 23 2.5 x 
T377A 38±1 676±27 5.6x 10 
H365A1 0.8 ± 0.1 —1100 7.3 x 102 
H504A 
H365A1 0.24 ± 0.02 2000 ± 300 1.2 x 102 
T377A 
Data for WT (wild-type), H365A, H5044 and H365A/H504A taken from M. Doherty 1999. Data for 
T3 77A and H365A./T3 77A taken from K. Pankhurst, 2002. ka/Km indicates the catalytic efficiency of 
each enzyme. For ease of comparison all K,,s are in micromolar units. 
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It can be seen from table 5.3 that all of the mutated forms of fcc 3 reduced fumarate at 
rates lower than the Wild-type. Reduction by H365A and H504A proceeded with 
rates approximately 10-fold lower and exhibited Km values that were higher by a 
factor of 10. Substitution of threonine 377 had more pronounced effects, resulting in 
an even lower kcat for fumarate reduction and a Km almost 30 times higher than that 
observed for wild-type fcc3. When mutants were constructed with two residues 
substituted with alanine, (double mutants H365A!H504A and H365A1T377A), 
fumarate reduction rates were over 600 and 2000 times slower than that of wild-type 
respectively. In addition, they exhibit K m values at the millimolar level, indicating that 
these mutants do not form the enzyme-substrate complex efficiently. The catalytic 
efficiency of fcc3 is measured by kcat/K m and it can be seen from the table that this 
value is lower relative to wild-type for the mutated forms of the enzyme. These 
effects will be discussed further in this chapter in relation to the crystal structures of 
H365A and T377A. 
5.2 Reduction of 2-methylfumarate by H365A, H504A and T377A 
It was hoped that the mutants listed in table 5.3 would be able to catalyse the 
reduction of substrates not turned over by the wild-type enzyme. Molecular 
modelling studies suggested that all forms of fcc 3 would be able to accommodate 
methacrylate (table 5.2) and perhaps methyl-3-aminocrotonate. T377A might be 
expected to bind both crotonate and trans-2-pentenoate since the OH group of 
threonine, which normally forms a hydrogen bond with the polar substrate, has been 
replaced by the non-polar alanine. Although the double mutant enzymes display poor 
activity for fumarate reduction, it was thought possible that H365A/T377A may be 
able to bind acids with bulky non-polar groups attached, for example cinnamic acid. 
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Table 5.4 Kinetic parameters for reduction of2-methylfumarate at pH 7.2 
1 cat (s') 	Km (PM) kcatlKm (M's') 
WT 9.0 	± 0.4 	32 ± 8.5 2.8 x 105 
H365A 0.11±0.01 	90±18 1.2x103 
H504A 0.22±0.01 	136±26 1.6x 10 
T377A 0.34 ± 0.03 	1260 ± 284 2.7 x 102 
H365A1 No measurable activity 
H504A 
H365A1 No measurable activity 
T377A 
Reduction rates for 2-methylfumarate reduction by Fcc 3. No activity was de:ectedfor the double 
mutants. 
Subsequent activity screens demonstrated that this was not the case. None of the 
mutants were able to catalyse reduction of any potential substrates other than fumarate 
and 2-methylfumarate. Kinetic parameters for 2-methylfumarate reduction by mutant 
forms of fcc3 at pH 7.2 are listed in table 4.4. The single mutants are all able to 
catalyse reduction of 2-methylfumarate at low rates, but the double mutant enzymes 
exhibited no measurable activity. This is reasonable considering that they are 
inefficient at fumarate reduction. 
5.2.1 pH profiles 
Michaelis plots for 2-methylfumarate reduction by H365A, H504A and T377A are 
shown in figure 5.3 along with pH profiles. It can be seen from the table 5.4 that 
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Figure 5.3 Observed rates of reduction of2-methylfumarate by H365A, H504A and 
T3 77A 

























6 	 7 	 8 	 9 	 10 
pH 
a) 2-methy1fumarate reduction rates at various substrate concentrations for H365A (pink), H504A 
(black) and T3 77A (green). b) Reduction rates ct various pHfor H365A (pink), H504A (black) and 
T377A (green). 
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H365A and H504A display lower K m values for 2-methylfumarate than for fumarate 
reduction, which suggests that they have a higher affinity for this substrate. However, 
the keat values are low so the catalytic efficiencies for the reduction of 2-
methylfumarate by these mutants are approximately 150 times lower than those 
calculated for fumarate reduction. 2-methylfumarate is likely to act as an inhibitor of 
fumarate reduction in both H365A and H504A as it does in WT because the Km 
values are lower than those observed when fumarate is the substrate. In the case of 
T377A, 2-methylfumarate does not appear to bind efficiently to the active site. The 
Km is twice as large compared to that observed when fumarate is the substrate so 
although the presence of 2-methylfumarate may reduce the rate of fumarate reduction, 
it is unlikely to be an effective inhibitor of reduction by this mutant. 
Figure 5.3 b shows how rates of 2-methylfumarate reduction are affected by variation 
in pH. The pH profile for H365A (shown in pink) fits to a bell shaped curve with two 
PKa'S of 7.4 ± 1.8 and 8.5 ± 1.4. H504A (shown in black) is also pH dependent with 
two PKa 'S of 6.9 ± 0.3 and 8.9 ± 0.8, but to a lesser degree as the curve is much flatter. 
It can be seen from the pH profile for T377A (shown in green in figure 5.3 b) that 
between pH 6.5 and 10, enzymatic activity remains approximately the same for 2-
methylfumarate reduction (For limitations of this assay see section 2.5) When 
fumarate is the substrate, the pH profile of reduction by T377A fits to a single pK a 
value of 9.1 ± 0.1 [Pankhust, 2003]. 
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Figure 5.4 Overlay of WT and H365A - hydrogen bonding of substrate at active site 
 
His 365 
Ala 3  
 
a) H365A (purple) over/aid on WT Hydrogen bonding interactions are shown in light blue dashes for 
WT and purple dashes for H365A. b) Crystal structure showing relative positions of arginine 402 to 
substrate for H365A (purple) and WT The NH 2 group at position A transfers a proton to C3. The NH 2 
at position B acts as a Lewis acid to stabilise build-up of negative charge during the transition state. 
Arginine 402 in H365A can transfer a proton to C3 but is unable to act as a Lewis acid also due to its 
position relative to substrate. 
ISM 
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5.3 Crystal structure of histidme 365 to alanine mutant 
The crystal structure of H365A Fcc3 had been previously solved to 1.8 A [PDB ID: 
1E39, Doherty et al, 2000]. Figure 5.4 shows crystal structures of the active site of 
H365A (purple) with fumarate bound, overlaid on Wild-type Fcc 3 with a malate-like 
molecule bound at the active site. Although there is the loss of a hydrogen bond when 
Histidine 365 is replaced with alanine, fumarate is still bound in an analagous manner 
to that observed in WT. There is a slight shift in position of the Cl carboxylate group 
of fumarate but it retains its twisted conformation, thus aiding polarisation of the C2 - 
C3 double bond, an important aspect of the reaction mechanism. Hydride transfer 
should not be affected because the distance between the N5 of the flavin alloxazine 
ring and C2 of substrate is the same as that measured in the WT active site. There is a 
change in the positioning of the active site acid arginine 402. As mentioned in the 
introduction, one NH 2 of the guanidinium group occupies position A (figure 5.4 b) 
relative to the substrate and acts as a Brønsted acid in that it donates a proton to C3 to 
complete the two-electron reduction of fumarate to succinate. The other NH2 
occupies position B and behaves as a lewis acid, stabilising the build up of negative 
charge (at the carbanion) that occurs during during the transition state. In H365A, 
the NH2 that would normally occupy position A is not ideally placed for direct proton 
transfer because it is 4.91 A from C3 of fumarate. The NI-I 2 that occupies position B 
in WT now occupies position A relative to fumarate, and at a distance of 3.0 A, 
donates a proton to C3 to complete the formation of succinate. Therefore arginine 
402 is still able to act as a Brønsted acid during catalysis in H365A, but its position 
relative to substrate means that it does not additionally function as a Lewis acid as it 
does in the WT enzyme. Therefore, reduction of fumarate to succinate would require 
a greater amount of free energy because the carbanion that forms during the transition 
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state is less stable than during catalysis by WT Fcc 3 . This would explain why H365A 
reduces fumarate at lower rates than wild-type Fcc 3 (table 5.3) and the loss of a 
hydrogen bond would explain the higher Km because fumarate would not bind as 
strongly to the active site. The low rates observed for 2-methylfumarate reduction 
(table 5.4) by H365A suggests that, despite binding more strongly to the active site 
than fumarate, the presence of the methyl group interferes with catalysis to a greater 
extent than it does in WT. This is illustrated by the fact that reduction of 2-
methylfumarate in WT is approximately 50 times slower than reduction of fumarate 
but for H365A it is approximately 450 times slower. The same is also true for H504A 
where reduction of 2-methylfumarate is —300 times slower than fumarate reduction. 
5.4 Crystal structure of T377A 
As previously discussed in chapter 3.2, the crystal structure of T377A was solved to 
2.0 A. The active site of T377A (green) with fumarate bound is shown in figure 5.5 
overlaid on to the wild-type active site. Because threonine has been replaced by 
alanine, there are two less hydrogen bonding interactions with fumarate. Substrate 
binds less well, so the enzyme-substrate complex that promotes catalytic reduction is 
less likely to form than it does in H365A, H504A (where a single Hydrogen bond has 
been removed) and WT. This results in the much larger Km values observed for 
reduction of fumarate and 2-methylfumarate by T377A (tables 5.3 and 5.4) relative to 
WT and the other single mutants. The orientation of fumarate relative to flavin and 
arginine 402 is the same as that seen in WT and distances for hydride and proton 
transfer are unaffected. However it can be seen that the C  carboxy late of substrate 
bound to T377A is not twisted out of plane as it is in the WT and H365A structures. 
This could partly explain why rates for fumarate reduction are lower. It might be 
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Figure 5.5 Crystal structure of T3 77A active site 
Ala 377 
__ His 365 
N
'0 
 Arg 402 
Am 
T3 77A (green) overlaid on WT. Hydrogen bonding interactions are shown in light blue dashes for WT 
and in green dashes for T3 77A. There are two less Hydrogen bonds in T3 77A so the substrate is no 
longer bound in the twisted conformation. The relative positioning of the other active site residues are 
unchanged. 
expected that the less polar environment caused by substitution of threonine to alanine 
would facilitate binding (and possibly reduction) of the unsaturated monoacids listed 
in table 5.2 But none of these substrates were bound or reduced. Unfortunately, 
there are no crystal structures available for the double mutants. In the case of 
H365A!T377A, the removal of three hydrogen-bonds would explain why it does not 
turn over fumarate very efficiently and why it cannot catalyse reduction of 2-
methylfumarate. 
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5.5 Substitution of Histidine365 with glycine 
As previously mentioned at the beginning of this chapter, only two methacrylate 
reductases have been discovered to date. One of these - FccA from Wollinella 
succinogenes - appears to have a similar active site to that of Fcc 3 . However, instead 
of a histidine at position 365 (or equivalent) there is a glycine residue (figure 5.1) for 
sequence alignment). It was hoped that substitution of H365 with glycine may alter 
the properties of the active site in such a way as to promote binding of one or more of 
the mono-acids listed in table 5.2. However, H365G was not able to catalyse 
reduction of methacrylate or any other substrate apart from fumarate. Compared with 
Figure 5.6 Michaelis plot offumarate reduction by H3 65G at pH 7.2 
8 
2 
100 	200 	300 	400 	500 	600 	700 	800 
[fumarate] pM 
Michaelis plot of observed rates of fumarate reduction by H365G versus fumarate concentration. 







r65 Gly 365 
rg 402 
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Figure 5. 7 Crystal structure of H3 65G active site overlaid on to the IFcc3 active site 
Crystal structure of H365G active site residues (red) overlaid on to iron-induced IFcc 3 (wild-type) 
active site 
WT Fcc3, H365G is not a very good fumarate reductase with a k cat of only 10.5 s_ I ± 
1.4, and a Km of 188 pM ± 65 (figure 5.6). The crystal structure of H365G was 
obtained in the "open" conformation without substrate bound as discussed in chapter 
3. Figure 5.7 shows the active site of 1 ­1365G overlaid on to the active site of iron-
induced Fcc3 also in the open conformation [Bamford et al. 1999]. The active site 
residues occupy slightly different positions and it can be seen that conversion of 
Histidine 365 to glycine creates a larger cavity. It is interesting that H365A is able to 
turn over 2-methylfumarate but H365G cannot. Perhaps the increased size of the 
active site cavity hinders correct orientation of the substrate required to facilitate 
reduction to 2-methylsuccinate. 
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5.6 Substitution of H365 and T377 with leucine, isoleucine and valine 
The mutants mentioned so far have all been substituted with a smaller residue (alanine 
and glycine) and so probably result in creating more space at the active site. Instead 
of just altering the space available it was thought worthwhile to attempt to change the 
properties of the active site by substituting H365 and T377 with residues that were 
non-polar but of similar size. Therefore H365 was substituted with leucine and with 
isoleucine and 1377 was substituted with valine (figure 5.8), again using site-directed 
mutagenesis. The T377V mutant was found to be capable of fumarate 
Figure 5.8 Substitution ofpolar H365 and T377 with hydrophobic residues 









-02C 	M3+  
OH 
Structures of amino-acids. Histidine 365 was substituted with Leucine or Isoleucine. Threonine 377 
was substituted with va/me. 
-93- 
Biocatalysis offumarate derivatives byflavocytochrome c 3 
























500 	1000 	1500 	2000 	2500 
[fumarate] jiM 
500 	1000 	1500 	2000 	2500 	3000 
[fumarate] j.tM 
Michaelis plots for reduction offumarate by H365L (a) and H3651 (b). It can be seen that the 
maximum observed rates for fumarate reduction are about five times faster when H3651 is used relative 
to H365L. Also there is a large difference in the observed K m values (table 5.5) 
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reduction but the enzyme lost activity quite quickly and reproducible Michaelis plots 
have not yet been obtained. Also, disappointingly, it did not appear to turn over any 
other substrate including those listed in table 5.1. Both H365L and H3651 were able to 
catalyse reduction of fumarate (figure 5.9 a and b) and 2-methylfumarate (figures 
5.10 a and b). Interestingly, H3651 catalysed reduction of fumarate at double the rate 
of H365L, with a k cat of 37.5 s_ I ± 2.4 compared to 16.5 s 1 ± 2.0. There is also a large 
difference in the Km values. The K m measured for fumarate reduction by H3651 was 
272 tM ± 55 compared with 1566 PM ± 367 (1.6 mM). When the catalytic 
efficiencies (table 5.5) are calculated it can be seen that H3651 is over ten times more 
efficient at catalysing the reduction of fumarate than H365L. When 2-methylfumarate 
is used as the substrate, both H365L and H3651 operate with similar k cat values (0.16 
S-1 ± 0.02 and 0.18 s'± 0.003 respectively). Despite the low rate however. H3651 has a 
Km of 50 jiM ± 5 which is close to that observed for 2-methylfumarate reduction by 
WT Fcc3 and the lowest value seen for the mutant forms of the enzyme. Because the 
Km for 2-methylfumarate reduction by H365L is so large (-5,300 jiM), it is a hundred 
times less efficient at catalysing reduction of this substrate than H3651. Activity tests 
were again performed to see if H365L and H3651 could catalyse reduction of any 
other substrates including those listed in table 5.2, but no activity was observed. 
There are no crystal structures available for these mutants so it is difficult to say why 
H3651 is more likely to form the enzyme-substrate complex than H365L. Double 
mutants H365L/T377V and H3651/T377V were also constructed but no activity tests 
have been performed on purified protein as yet. However, given the low rates of 
reduction catalysed by the single mutants, it is unlikely that they will reduce any of 
the substrates listed in this chapter with any efficiency or even at rates that would be 
detectable. 
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2 	 4 	 6 	 8 	 10 
[2-methylfumarate] mM 
200 	400 	600 	800 	1000 
[2-methylfumarate] iM 
Rates of2-methylfumarate reduction by H365L at different substrate concentrations (in mililimolar). 
Reduction rates for H3651 at different substrate concentrations (in micromolar). Michaelis plots 
were generated using Microcal Origin 7.0. k, and Km values are listed in table 5.5. 
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kcat (sd ) 
509±15 
16.5 ± 2.0 
37.5 ± 2.4 
9.0 ± 0.4 
0.16± 0.02 
0.18 ± 0.003 
Km (tiM) 
25 ± 2 
1566 ± 367 
272 ± 55 
2-methylfumarate 
32 ± 8.5 
—5300 
50±5  
ki at/Km (M's') 
2.0 x 10 
1.Ox 104 
1.4x 10'  
2.8 x 10' 
3.Ox 10' 
3.6 x 103 
Rates offumarate and 2-methylfumarate reduction by H365L and H3651. the K m 's are listed in 
micromolar units for ease of comparison. 
5.7 Future Work and conclusion 
Although molecular modelling studies had suggested that the active site of Fcc 3 might 
accommodate some of the potential substrates listed in table 5.2, none of the 
substituted enzymes were able to catalyse the reduction of molecules not turned over 
by wild-type Fcc3. Substitution of active site residues resulted in changes to the 
kinetics of fumarate and 2-methylfumarate reduction, but did not enable the enzyme 
to bind alternative substrates. It is possible however, that other combinations of active 
site substitutions (not yet tested) could yield different results. In the case of H365G, 
substitution resulted in a 50-fold decrease in the rate of reduction of fumarate relative 
to the wild-type enzyme and it does not appear to catalyse the reduction of any of the 
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chemicals listed in table 5.2. However, additional substitutions that could be made at 
position 377 (threonine in wild-type Fcc3) may further alter the enzyme's substrate 
binding range and activity (the Wollinella succinogenes methacrylate reductase has a 
valine residue at the equivalent position [Gross et al, 2001]). Also it would be useful 
to obtain a crystal structure of H365G in the "closed" conformation with fumarate 
bound. This would provide additional information about changes in the relative 
positioning of other active site residues which would enable determination of why the 
rate of fumarate reduction is 5-fold lower than that of the H365A enzyme. On the 
other hand, all research so far seems to indicate that Fcc 3 is a highly specific fumarate 
reductase. If this is the case, then it is unlikely that any substitutions will result in the 
enzyme being able to catalyse the reduction of any potential substrates other than 
fumarate or 2-methylfumarate. 
Summary 
During the course of this project, three new crystal structures of Fcc3 have been 
obtained including one (H365G) in the "open" conformation. It has been shown that 
Flavocytochrome c3 can catalyse the reduction of 2-methylfumarate, a molecule 
previously thought to be only an inhibitor of the enzyme. Crystallography of the 
Fcc3/2-methylfumarate complex has allowed us to visualise the binding of this 
substrate at the active site of the enzyme. This structure, in combination with the 
previously proposed mechanism for catalysis by Fcc 3 [Taylor et a!, 1999], has enabled 
us to predict the trajectories for hydride and proton transfer to 2-methyiflimarate. This 
suggested that the resulting product should be (S)-methylsuccinate and this has been 
confirmed by CD spectroscopy adding strong support to the validity of the proposed 
mechanism. It was thought that substitution of active site residues could possibly 
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alter the substrate specificity of Fcc 3 . However, activity tests have shown that none of 
the substitutions enabled the enzyme to reduce any of the alternative substrates tested, 
or improved the enzyme's ability to reduce fumarate or 2-methylfumarate. Also, none 
of the chemicals tested altered the activity of fumarate reduction when included (in 
excess) in the fumarate reductase assay, indicating that none of them bound to the 
active site. All substitutions resulted in a detrimental effect on the rates of reduction 
of fumarate and 2-methylfumarate compared to that of the wild-type enzyme, 
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Appendix 2 
Michaelis-Men ten equation 
The kinetics of many enzymes can be described by the Michaelis-Menten model. 
k 1 	k2 
E+S ES— E+P 
k- 1 
This model describes the reversible formation of an enzyme-substrate (ES) complex 
intermediate (k 1 and k- 1 ), which then dissociates in a rate-limiting step to form 
product and free enzyme (k2). When the concentration of substrate is saturating 
compared to that of enzyme the concentration of ES remains constant so that: 
d[ESJ = k1 [EJ IS] - k., IESI - k2 [ESI = 0 
dt 
Therefore: 
IESI = k 1 [EJ (SI 
k.. 1 + k2 
The Michaelis constant Km is the concentration of substrate when the rate of reaction 
is 50 % of that of the maximum (V max) and can be represented as: 
Km =k.. 1 +k2 
This enables equation - to be simplified to: 
IESI = IE1 IS1 
Km 
The total concentration of enzyme present is taken as the initial concentration at time 
zero (E0) and is equal to the concentration of enzyme bound to substrate (ES) minus 
the concentration of free enzyme [E]. 
(El = EE0I - [ESI 
The concentration of substrate-bound enzyme can thus be written as: 
[ES] = ([Ep] - IES1) 151 
Km 
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Which rearranges to give: 
IES1JELL.I 
Km + II 
The rate of the reaction (V) is the rate of product formation: 
d[P] = k2 [ES] 
dt 
Combining equations - results in the Michaelis-Menten equation 
V=k2 IE0I1S1 
K m + I1 
Where k2 is the 'cat  or turnover number of the particular enzyme. 
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Appendix 3 
Nucleotide and protein sequences of wild-type Flavocytochrome c 3 
Fcc including signal sequence and modified internal 
EcoRI and Hindffl sites (571 amino acid residues. 1713bp). 
ark  
16 	23 	30 	40 	50 	60 
tactttt:ctactqaCcaca5aacgatgtaat tacccgtglegtccgga:ac 
K K M N t A V C I A I L N G 7 A G L N 
ggcdctgCLgtLguggctgataacttagctgaatzteatgtacaaaaccaagaatgcgat 
70 	80 	90 	100 	10 	120 
ccqtacgacaacgccacta t.gaatccttaaagtactgtt.tggttcttacaca 
G ¶ A V A A D N L A E F H V Q N Q S C D 
agccgccatacaccaga tggtgactgtcaaacgacagcetaacctacçaaaataccc3a 
130 	140 	150 	160 	170 	:so 
SC H T P DG EL S ND S L P YE NT Q 
190 	200 	2:0 	220 	230 	240 
CV S C HG P LA E V A E PT K NE MY 
aatctcatcttctcat ttccctgccgaagtagcttgtacctcatgccacagcgcacac 
250 	260 	270 	280 	290 	330 
ctacgagtacgaagp-gtaaagggticcgcttcatcqaacatggagtacggtgtcgcgtg--g  
N A 4 A S H F PG E VA CT SC H S All 
gaaaaatcgatqgrgtattg:ctctt ttartacatgc(tttgct 
----:-----I---:----(----:----H.-:--H----:----I 
310 	323 	330 	340 	350 	340 
cttt tagctaccacat aacactgagacgçtgt cgaagctaaagotgtac9gaa:acga 
E KS MV'( CT) SC H S F D F NM P Y A 
aaaaaa tggctacgtgacgagccgacattgctgaattggccaaagacaaatcaacgt 
370 	383 	39C 	400 	413 	420 
ttttt Lac cgatgcactctcggcgataccttccggtttczgtttag:cttgcd 
K K W I. 	0 	3 T I A K b A 	I) ? S S it 
-113- 
Biocatalysis offumarate derivatives byflavocytochrome c3 
cagqctgctcttgc tagccacctcacgatac tgttgacatgttgtcggttctggc 
---------------------------- 
430 	440 	450 	460 	470 	480 
gtccgacgagaacgatcgcgtggagtgctatgacaactgcatcaccaacagccaagaccg 
Q AA LAS A P H D TV D V V V V CS C 
ggcgcaggtttctcaucvgcaatatcagcaacagacagtggtgctaaagtcattcttatt tat t 
- 
490 	500 	510 	520 	530 	540 
Ccgcgtccaaagagtcgccgt tatagtcgttgtctgtcaccacgatttcagtaagfl 
GAG F S A A I S AT D S GA K V ILl 
gaaaaagaqcctgt 
--------- 
550 	560 	570 	580 	590 	600 
ctttttctcggacaataaccaccattacgattcaatcgacgcccaccgtacttgcgacga 
EKE P VI G C N A K LA AG GM N A A 
tggactgatcaacaaaaagccaaaaaaattaccgacagcccagagttaatgtt cgaagac 
--------- 
610 	620 	630 	640 	650 	660 
W TD Q Q K A K K IT D S P ELM FED 
aceataaaggtgGccaaaacataaatgaccctgcat tagttaaagtat taagctcacac 
670 	680 	690 	700 	710 	720 
tggtactt tccaccggttttqtat t tactgggacgtaatcaatttcataattcgagtg 
T MI( G C Q N I ND P AL V K V 	S S H 
tctaaaac tctgt tgattgga 
--------------------I 
--------- 
730 	740 	750 	760 	770 	780 
agat ttctgagacaactaacctactgcga tacecacggctaaattgactacccgtae 
S K 	SVD W 	TAM GAD LTD VOM 
atgggtggcgc&tctgttaatCgtgcgcatcgtccaaccggtggtgcgggtgtcggtgct  
790 	800 	810 	820 	830 	840 
H G 	A S V N R A HR PT C GAG VGA 
catgttgttcaagtactt:atgataa tgcagtgaaacgcaatatcgacttacgcatgae 
850 	860 	870 	880 	890 	900 
gtacaacaagttcatgaaatactattacgtcactttgcgttatagctgaatgcgtacttg 
H VV Q V L Y DNA V K RN ID L R MN 
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actcqcggCat 
I ----------___-:----I- --- : .-- 1 --------- 
910 	920 	930 	940 	950 	960 
tgagcgccgtaacttcacgaatttctactatttccgtgacaatttccataagaccaattc 
T R 	1EV L K D D KG TV K G I L V K 
970 	980 	990 	1000 	1010 	1020 
ccctacatgtttccaatgatgacccactttcggctaLcgccattagaatcgttgccca cca 
G MY KG Y Y W V K A D AV 1 LA? G C 
ttgctaaaaataacgagCgtgtCgCaaaaCt tgatccttcactaaaaggCt tt&tctCt 
1030 	1040 	1050 	1060 	1070 	1080 
F AK NNE R V A K L D PS L KG F IS 
actaaccaacctggtgcagcaggtgatggactggatgtagctgaaaatgcgggtggcgca 
1090 	1100 	1110 	1120 	1130 	1140 
gatggttggaCCaCgtCatCCaCtaCCtgaCCt&catcgat ttacgCcCaCcgCgt 
TN Q PG A V G 	G L, DV A E NAG GA 
tgaaagacatgcagtatatCCaagCtC&CCCaaCaC tatctgttaaaggtggCgtaatg 
1150 	1160 	1170 	1180 	1190 	1200 
aactttctgtacgtcatataggttcgagtgggttgtgatagacaatttccaccgcattac 
L X 	N Q Y I Q AN F 'I' L S 	KCGV N 
gteactgaagcggracgtggtaatggtgcgattttggttaaccgtgaaggtaagcgttt C 
1210 	1220 	1230 	1240 	1250 	1260 
agtgacttcgccatgCaCCattaCCaCgCtaa6aCCaattggdttat tcgcaaag 
VT E A V R G N GAIL V 	RE G KR F 
gttaacgaaattactaCtCgtgataaagCatCtgCcgctatct tagcgcaaaCCggtaa 
1270 	1280 	1290 	1300 	1310 	1320 
caattgctttaatgatgagcactatttcgtagacggcgatagaatcgcgtttggccattt 
V N E I T T K D K A S A A I L A Q T G K 
tcagcttatttgatttttgatgattctgtgcgtaagtcactgtcaaaaattgataagtat 
1330 	1340 	1350 	1360 	1370 	1380 
agtcgaataa&CtaaaaaCtaCtaagaCaCgCattCagttt tttaactattCat& 
SAY L 	F D D S V R 	S L S K ID KY 
-115- 
Biocatalysis offumarate derivatives byfiavocytochrome c 3 
attggtttaggtgttQcaccaacggcagatagcctagttaaattagtaaaatggaaggt 
----:----I----:-----I----:-.---I----:----j --------- 
1390 	1400 	1410 	1420 	1430 	1440 
taaccaaatccacaacgtgg tgccgtctatcggatcaatttaatccattttaccttcca 
I G L G VA PTA D S L 	XL G K M E G 
at tgacggcaaagcactgactgaaac tgtcgcgcgttacaacagct t.agtgagtagcgt 
1450 	1460 	1470 	1480 	1490 	1500 
taactgccgt ttcgtgactac tttacagcgcgcaatgttgtcgaatcactcatcgcca 
ID G K ALT E 	TV AR Y N S L 	S S G 
aaagacactgattttgagcgtccaaacctaccgcgcgcacctaacgaaggtaactac tat 
1510 	1520 	1530 	1540 	1550 	1560 
ttctgtgactaaaactcgcagtttggatggcgcgcgtgaattgcttccattgatgata 
EDT DL ER P N L PR AL N E G NY Y 
gcaattgaagttacacctggtgttcaccacactatgggtggcgtgatgatcgacactaaa 
1570 	1580 	1590 	1600 	1610 	1620 
cgttaacttcaatgtgaccacaagtggtgtgatacccaccgcactactagctgtgatt t 
A 1EV P PG V H HP MG GV14 ID TX 
gctgaagteatgaatgctaagaagagttatccctggcctgtatggtgctggtgaggtt 
1630 	1640 	1650 	1660 	1670 	1680 
cgacttcagtacttacgattcttctccaatagggaccgaacataccacgaccactccaa 
A £ V 	NAI( K 	VIP G L Y GAG E  
actggcggtgt tcatggtgctaaccgct taggtqgtaatgctatttcagacatcatcacc 
1690 	1700 	1710 	1720 	1730 	1740 
tgaccgccacaagtaccacgattggcgaatccaccattacgataaagtctgtaqtagtgg 
PG CV H GA N R L CC N A IS DX IT 
ttcggtcgc tagcgggtgaagaagctgcaaaatattctaaaaagaactaa 
1750 	1760 	1770 	1780 	1790 	1800 
aagccagcgaatcgcccacttcttcgacttttataagatttttcttgatt 
F G R 	AGES 	A A KY S K K 	* 
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Appendix 4 
Mulagenic primers for H365L, H3651 and T3 77V 
The following primers were designed to substitute Histidine 365 with either leucine or 
isoleucine and threonine 377 to valine. Other mutants used for studies had been 
previously made. 









5'CAGATAGTGTTGGGATAGCTTGGATATACTGC 3 ' 




5'CCACGTACCGCTTCAACGACCATTACGCCAC 3 ' 
-117- 
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Appendix 5 
JUPAC names for chemicals listed in table 5.2 
2-butenedioic acid (fumarate) 
2-methyl-2-butenedioic acid (2-methylfumarate) 
2-methyl-2-propenoic acid (methacrylate 
2-butenoic acid (crotonate) 
Trans-2-pentenoic acid (trans-2-pentenoate) 
Trans-2-methyl-2-pentenoic acid (trans-2-methyl-2-pentenoate) 
Methyl-3 -amino-2-butenoic acid (methyl-3 -aminocrotonate) 
3-phenyl-2-propenoic acid (cinnamic acid) 
2-butenedioic acid dimethyl ester (dimethylfumarate) 
2-butenedioic acid monoethyl ester (monoethylfumarate) 
-118- 
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Abstract The soluble fumarate reductase (FR) from Shewa-
nella frigidimarina can catalyse the reduction of 2-methylfuma-
rate with a k., of 9.0 s and a KM of 32 sM. This produces 
the chiral molecule 2-methylsuccinate. Here, we present the 
structure of FR to a resolution of 1.5 A with 2-methvlfumarate 
bound at the active site. The mode of binding of 2-methy1fuma-
rate allows us to predict the stereochemistry of the product as 
(S)-2-methylsuccinate. To test this prediction we have analysed 
the product stereochemistry by circular dichroism spectroscopy 
and confirmed the production of (S)-2-methylsuccinate. 
© 2006 Federation of European Biochemical Societies. Published 
by Elsevier B.V. All rights reserved. 
Keywords. Fumarate red uctase; Flavocytochronie ci; 
2-Methylfumarate; Mesaconate; 2-Methylsuccinate 
1. Introduction 
During anaerobic respiration many bacteria can utilise 
fumarate as a terminal electron acceptor. In most cases bacte-
rial fumarate reductases (FRs) are cytoplasmic, membrane-
associated complexes related to the succinate dehydrogenases, 
and contain iron-sulfur centres and flavin adenine dinucleotide 
(FAD) as cofactors [1,2]. In contrast, Shewanella species pro-
duce a soluble periplasmic FR which contains four c-type 
heme groups and one FAD, and as such is designated a flavo-
cytochrome c3 . A number of crystal structures of the FR from 
Shewanellafrigidimarina have been reported [3-5]. The highest 
resolution structure is to I.8A (PDB ID IQJD). and based 
upon this structure a mechanism for fumarate reduction has 
been proposed [3]. This mechanism involves the use of 
Arg402 as the active-site acid according to the scheme shown 
in Fig. I, and is corroborated by further studies on site-direc-
ted mutant forms of the enzyme 161. 
The atomic coordinates have been deposited in the protein data 
bank, entry IYOF. 
Corresponding author. Fax: +44 131 650 6453. 
E-mail addresses: S.K .Chapman@ed.ac.uk , 
sk1®stalhnail.ed.ac.uk  (S.K. Chapman). 
Abbreviations: FR, fumarate reductase; FAD, flavin adenine dinucle-
otide; CD, circular dichroism spectroscopy 
Fumarate reduction by FR is known to be competitively 
inhibited by 2-methylfumarate (also known as mesaconate) 
with a K of 1.0 sM. However, we show in the present paper 
that 2-methylfumarate is actually a substrate for FR. Unlike 
fumarate reduction by FR, which leads to the formation of 
the achiral product succinate, the reduction of 2-methylfuma-
rate should result in the production of the chiral molecule 
2-methylsuccinate. Depending upon the mode of binding of 
2-methylfumarate at the active site of the enzyme, the product 
will be either (S)- or (R)-2-methylsuccinate. In order to investi-
gate this we have obtained the crystal structure of FR with 2-
methylsuccinate bound and have examined the FR-catalysed 
reduction of 2-methylfumarate by steady-state kinetics. In 
addition, we have carried out an electrocatalytic bulk reduction 
of 2-methylfumarate by FR, and identified the stereochemistry 
of the resultant 2-methylsuccinate by circular dichroism spec-
troscopy (CD). The results confirm our predicted trajectories 
for hydride and proton transfer in the catalytic mechanism. 
2. Materials and methods 
2.1. Protein expression and purification and determination o/FAD 
content 
Wild type FR was expressed and purified as previously reported [7]. 
The FAD content of the FR preparations was determined by the meth-
od of Macheroux [8]. All steady-state rate constants were corrected for 
the percentage of FAD present. 
2.2. Crystallisation and refinement 
Crystallisation of wild-type FR was carried out by hanging-drop 
vapour diffusion at 4 'C in Linbro plates. Crystals were obtained with 
well solutions comprising 100 m Tris-l-lCl buffer (pH 7.8-85) 
(measured at 25 °C). 80 mM NaCl, 16-19% PEG 8000, and 1 mM 
2-methylfumarate. Hanging drops (4 .tl volume) were prepared by 
adding 2 jil of 6 mg/ml protein (in 10 m Tris-HCI pH 8.5) to 2 jiJ 
of well solution. After approximately seven days needles of up to 
I mm x 0.2 mm x 0.2 mm and plates of up to 0.5 mm x 0.5 mm x 
0.2 mm were formed. Crystals were immersed in a solution of 
100 mM sodium acetate buffer (pH 6.5), 20% PEG 8000. I mM 2-
methylfumarate, and 80 mM NaCl, containing 23% glycerol as a 
cryoprotectant, prior to being mounted in nylon loops and flash 
cooled in liquid nitrogen. A data set was collected to 1.5 A at station 
14.1 (i. = 0.975A) at SRS Daresbury using an ADSC Quantum 4 
CCD detector. Crystals belonged to space group P2 1 with cell dimen-
sions a = 45.449 A, b = 91.687 A, c = 78.287 A. and /3 = 91.13°. Data 
processing was carried out using the HKL package [91. The wild-type 
FR structure (PDB ID IQJD). stripped of water, was used as the ini-
tial model. Electron-density fitting was carried out using the program 
Turbofrodo (10] and structure refinement by using Refmac [Il]. 
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Fig. I. The reaction mechanism for fumarate reduction in FR (this is 
an abbreviated version of the mechanism proposed by Taylor et al. [31). 
The substrate is polarised by interactions with charged residues 
facilitating hydride transfer from N5 of the reduced FAD to C2 of the 
substrate. Arg402 is ideally positioned to donate a proton to C3 of the 
substrate, resulting in the formation of succinate. Arg402 is immedi-
ately reprotonated via a proton pathway involving Arg38 I and 
Glu378. 
2.3. Steady-state kinetics 
The steady-state kinetics of 2-methylfumarate reduction were fol-
lowed at 25 °C as described by Turner et al. [121. The 2-methylfuma-
rate-dependent reoxidation of reduced methyl viologen was 
monitored at 600 nm using a Shimadzu UV-PC 1501 spectrophotom-
eter. To ensure anaerobicity, the spectrophotometer was housed in a 
Belle Technology glovebox under a nitrogen atmosphere with the 02 
level below 5 ppm. Assay buffers contained 0.45 M NaCl and 
0.2 mM methyl viologen and were adjusted to the appropriate pH val-
ues using 0.05 M HCl or NaOH as follows: Tris-HCI at pH 7.0-9.0. 
MES/NaOH at pH 5.4-6.8. and CHES/NaOH at pH 8.6-10.0. The 
viologert was reduced by addition of sodium dithionite until a reading 
of -1 absorbance unit was obtained (corresponding to -.80 1iM re-
duced methyl viologen). The concentration of reduced methyl viologen 
could be varied from 20 to 100 (SM with no effect on the rate of reac-
tion. A known concentration of the enzyme was added and the reac-
tion initiated by addition of 2-methylfumarate (0-I mM). 
Kinetic parameters KM and k 0 , 1 were determined from steady-state 
results using non-linear-regression analysis (Microcal Origin software). 
2.4. Electrocatalytic reduction of 2-niethylfu,naraie 
In order to carry Out subsequent CD analysis, millimolar concentra-
tions of product were required. Therefore, bulk reduction of 2-methyl-
fumarate was carried out under anaerobic conditions at 25 0C in 
0.05 M MOPSINaOH buffer, pH 7.0, containing 0.5 M KF. 50 jiM 
methyl viologen. and 5 mM 2-methylfumarate. The concentration of 
FR was approximately I jiM. The electrodes used were platinum with 
a Ag/AgCI reference electrode. The potential was held at -0.6 V until 
reaction completion was indicated by cessation of current flow. After 
completion protein was separated from product by centrifugation 
through a 10 kDa membrane (Millipore). 
2.5. Circular dichrois,n spectroscopy 
CD spectroscopy was carried out using a Jasco J-810 spectropolar-
imeter and a I cm pathlength quartz cell. CD spectra of the product 
was compared with the spectra of enantiomerically pure solutions of 
500 j.tM (R) and (S)-methylsuccinate (Sigma). 
3. Results and discussion 
3. 1. Crystal structure of FR with 2-methy0umarate hound 
A data set to 1.5 A resolution was used to refine the struc-
ture to a final R-factor of 15.08% (Rir = 18.35%), data collec-
tion and refinement statistics are summarised in Table I. The 
Table I 
Data collection and refinement statistics 
Resolution (A) 24.0-1.5 
Total number of reflections 678 137 
Number of unique reflections 99564 (9590)' 
Completeness (%) 97.2 (94.0)' 
JI[o(f)] 21.0 (3.!)' 
Rm.orgo (o/)b 4.8 (37.3)' 
R,,,.,1 (%)0 15.08 
Rr,-,... (%)0 18.35 
RMSD from ideal values 
Bond lengths (A) 0.014 
Bond angles (°) 1.5 
Ramachandran analysis 
Most favoured (%) 88.1 
Additionally allowed (%) 11.7 
'Values in parentheses indicate statistics for the highest resolution shell 
(1.55-1.50 A). 
bRmcrgn = 	, 1(h) - 1Ah)V,,, 1,4h), where 11(h) and 1(h) are the ith 
and mean measurement of reflection 6. respectively. 
= EJF. - F,j/,,F0 , where F. and F, are the observed and 
calculated structure factor amplitudes of reflection 6. respectively. R 1, 
is the test reflection data set. 5/n selected randomly for cross validation 
during crystallographic refinement. 
final model consists of one protein molecule comprising resi- 
dues 1-568, four hemes, one FAD, one sodium ion, one 2- 
methylfumarate molecule, and 1249 water molecules. The 
atomic coordinates have been deposited in the protein data 
bank, accession code IYOP. 
The binding of 2-methylfumarate is illustrated by the F0-
F0 omit map shown in Fig. 2A. As found for other FR 
structures, residues 569-571 at the C-terminus of the enzyme 
could not be located in the electron density maps. The 
RMSD fit of all backbone atoms between this model and 
the earlier wild-type enzyme structure (PDB ID IQJD) [3] 
is 0.2A, indicating no major differences between the two 
protein structures. 2-Methylfumarate is found at the active 
site of the enzyme in the same twisted conformation ob-
served for the malate-like molecule (henceforth referred to 
as malate for the sake of simplicity) in the original crystal 
structure (PDB ID IQJD) [31 and for fumarate in structures 
of mutant forms of the enzyme (e.g., PDB ID 1JRX) [6]. The 
binding of 2-methylfumarate and malate (from the structure 
of Taylor et al. [31) to FR is shown in Fig. 2B. The ligands 
are completely superposable with the exception of the C2-
substituents. Thus, bound 2-methylfumarate maintains the 
same interactions with the protein as displayed by malate. 
These include an electrostatic interaction between the Cl-car - 
boxylate group and the positively-charged sidechains of 
Arg544 and His504 which serve to polarise and activate 
the double bond for hydride attack by FAD. The C4-carbox- 
ylate end of 2-methylfumarate is hydrogen bonded to several 
residues including His365 and Thr377. The interactions of 2- 
methylfumarate at the active site of FR are shown in 
Fig. 2C. The mechanism of 2-methylfumarate reduction is 
assumed to be the same as that shown for fumarate in 
Fig. 1, and is proposed to involve proton delivery via a path- 
way comprised of Arg381, Glu378, and Arg402. In the 2- 
methylfumarate-bound protein all proton transfer distances 
are identical to those observed in the malate-bound struc- 
ture, as is the hydride transfer distance from FAD to sub-
strate. 
The physiological reaction of FR results in the formation 
of the achiral product succinate. In contrast to this, reduction 
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Fig. 2. (A) Stereoview of the region surrounding the FAD and bound 
2-methylfumarate in FR. The electron density shown is a simulated 
annealing omit map calculated using Fourier coefficients F0-F. where 
F. and F are the observed and calculated structure factors, respec-
tively, the latter based on the final model. The contour level is 3a. 
where a is the RMS electron density. (B) The left panel shows 2-
methylfumarate at the active site of the enzyme while the right panel 
shows malate in the active site (from PDB 1DB IQJD 131). (C) 
Stereoview of the active site of FR with 2-methylfumarate bound. 
Residues important for substrate binding and catalysis are shown. The 
figure was made using BOBSCRIPT (13) and RASTER 3D [14). 
of the double bond in 2-methylfumarate will lead to forma-
tion of either (R)- or (S)-methylsuccinate, depending upon 
the mode of binding of 2-methylfumarate during catalysis. 
This is shown schematically in Fig. 3. Specifically, when 2-
methylfumarate is bound as observed in the structure re-
ported here then the product will be (S)-methylsuccinate 
(see Fig. 3A). If 2-methylfumarate had bound in a mode 
analogous to that seen for malate (see Fig. 213), i.e., with 
the methyl group in the same position as the malate 2-hydro-
xyl group, then the product would be (R)-methylsuccinate 
(see Fig. 3B). In this way, the crystal structure of the en-
zyme/substrate complex enables the prediction of the hydride 
and proton trajectories and hence the stereochemistry of the 
chiral product. 
1679 
3.2. Steady-state kinetics 
The ability of FR to catalyse 2-methylfumarate reduction 
was assayed at a range of pH values between 6.0 and 10.0. 
At pH 7.2, the FR-catalysed reduction of 2-methylfumarate 
gave a k00 value of 9.0 ± 0.4 s_ I and a KM of 32 ± 8 sM. At 
the same pH, fumarate gives rise to a k., value of 
509 ± 15 s 1 and a KM of 43 ± 10 sM. Thus although both 
substrates exhibit similar KM values, the k., value seen for 
fumarate is some 50-fold larger than that seen with 2-meth-
y1fumarate. The structural data would suggest that there is 
no problem with the binding and orientation of 2-methyl-
fumarate and so it is unlikely that the fall in k 0 is due 
to steric reasons. The more likely reason is the positive 
inductive affect of the methyl group. It has been proposed 
that the transition state for the reaction involves the build 
up of negative charge on the substrate [3]. This suggestion 
is consistent with our results, since the methyl group would 
disfavour the build up of negative charge, raising the energy 
of the transition state and consequently lowering the k at 
value. 
3.3. Characterisation of electrocatcs/vtically produced 
2-meihylsuccinate using CD speciroscopy, 
The ability to use an electrode to drive fumarate reduction 
by FR has been previously demonstrated [12], and electro-
chemistry has become a valuable technique in the study of 
the enzyme. Thus, in order to produce enough product for 
analysis by CD spectroscopy, we carried out an electrocata-
lytically driven bulk enzymatic reduction of 2-methylfuma-
rate. The CD spectrum of the 2-methylsuccinate produced 
was compared with those of pure (R)- and (S)-methylsucci-
nate, and these are shown overlaid in Fig. 4. It can be seen 
from this figure that the product spectrum is identical to 
that of pure (S)-methylsuccinate, indicating that reduction 
of 2-methylfumarate by FR results in the production of 
(S-methylsuccinate. 
3.4. Conclusions 
We have shown that FR can catalyse the reduction of 2-
methylfumarate, a molecule previously thought to be only 
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Fig. 3. Schematic representation of 2-methylsuccinate generation by 
FR. Panel (A) illustrates the situation as observed in the crystal 
structure resulting in (S)-methylsuccinate. Panel (B) shows the 
production of (R)-methylsuccinate if 2-methylfumarate were bound 
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Fig. 4. CD spectra of product 2-methylsuccinale (black). (R)-2-
methylsuccinate (red), and (S)-2-methylsuccinate (blue). All the 
compounds were at the same concentration of 5 mM. Spectra represent 
an average of 5 scans at 10 nm per minute. 
an inhibitor of the enzyme. Crystallography of the FR:2-
methylfumarate complex has allowed us to visualise the 
binding of this substrate at the active site of the enzyme. 
This structure, in combination with the previously proposed 
mechanism for catalysis by FR [3], has enabled us to predict 
the trajectories for hydride and proton transfer to 2-methyl-
fumarate. This suggested that the resulting product should 
be (S)-methyisuccinate and this has been confirmed by CD 
spectroscopy adding strong support to the validity of the 
proposed mechanism. 
We note that the ability of FR to produce chiral com-
pounds from achiral precursors at millimolar concentrations 
may have future applications. The mild reaction conditions 
and use of an electrode as a reductant could provide an effi-
cient and inexpensive route to further compounds. Clearly 
the scope of the method is determined by the ability of the 
enzyme to accommodate and catalyse the reduction of fur-
ther compounds. Current efforts are centred upon determin-
ing which precursor compounds are viable substrates for 
wild-type FR, and a programme of site-directed mutagenesis 
is under way in an effort to alter the substrate specificity of 
the enzyme and therefore maximise the applicability of the 
method. 
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